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ABSTRACT OF DISSERTATION 
 
 
 
 
TOBACCO-FREE PRISON POLICIES AND HEALTH OUTCOMES AMONG 
INMATES 
 
This study was the first to examine the effect of tobacco policies in prisons on the 
health of inmates. Kentucky has two types of tobacco policies in its 16 state prisons: 
indoor smoke-free policies, where smoking is allowed outdoors and tobacco-free policies, 
in which no tobacco of any kind is allowed on the grounds of the prison. The smoking 
rate of inmates is three times higher than that of current smokers in the non-incarcerated 
population which results in high rates of tobacco-related health conditions such as heart 
disease and lung cancer. 
 
A literature review discussed the evolution of tobacco policies in prisons, the 
motivations for strengthening policies in prisons and the unintended consequences. 
Health outcomes in the non-incarcerated population on the benefits to cardiovascular and 
respiratory health following passage of smoke-free laws in public places were reviewed. 
No studies have been found on the health outcomes of inmates with varying degrees of 
smoke-free or tobacco-free policies.  
 
The first study was a time series analysis comparing the frequency of medication 
refills for asthma and/or COPD before and after a tobacco-free policy was implemented. 
Short-acting inhaler refills decreased in the first few months following the tobacco-free 
policy date but returned to baseline within 12 to 15 months. Rapid turnover of inmates, 
minimum security status of the prisons, and possible loosening of enforcement may have 
been related to the gradual increase in use.  
 
The second study was a survival analysis on the time to an inmate’s first acute 
myocardial infarction (AMI) with tobacco policy status (tobacco-free or smoke-free) of 
the prison as the primary predictor variable. Controlling for the multiple movements over 
time, facilities, co-morbidities, past smoking history, age and race, there was a 2.87 
hazard for AMI for time spent in a smoke-free (indoors) prison compared to a tobacco-
free prison. This finding may be due to the fact that tobacco is considered contraband 
after prisons become tobacco-free and inmates risk disciplinary action by smuggling or 
using tobacco in the prison, thereby reducing secondhand smoke for non-smokers and 
probably reducing the consumption of current smokers.  
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CHAPTER 1: INTRODUCTION 
Tobacco use is the leading cause of preventable death in the world according to 
the World Health Organization (WHO, 2006). Tobacco is responsible for 21% of all 
deaths in the United States including 89% of all lung cancer deaths. Rates of current adult 
smoking prevalence have decreased  in the United States over the past 12 years from 
24.7% in 1997 to 20.6% in 2009 (CDC, 2010). Inmates, however, smoke tobacco at 
higher rates than the general population. Estimates of the current smoking rate among 
male and female inmates range from 42% to 91% with an average of 70% to 74% 
(Cropsey, Eldridge, & Ladner, 2004; Connell, Winter, & Curd, unpublished, 2007). 
Compared to the non-incarcerated population, inmates tend to be of lower socioeconomic 
status, have fewer years of education, and are more likely to exhibit high-risk behaviors 
such as drug abuse including intravenous drug use. Higher levels of secondhand smoke 
(SHS) exposure have been reported in homes of people with lower incomes and among 
non-Hispanic blacks (MMWR, 2008). Further, few inmates have health insurance when 
not incarcerated. On average, only 15% of inmates report having health insurance in the 
year before or after incarceration (Wang, et al., 2009). These factors increase the 
likelihood for chronic disease among the inmate population.  
In state prisons the leading causes of death are heart disease and cancer, consistent 
with the top two causes of mortality in the United States  (Mumola, 2007; Xu, Kochanek, 
Murphy, & Tejada-Vera, 2010). Over half of the deaths among inmates are caused by 
heart diseases (27.3%) and cancer (23.3%) (Mumola, 2007). Lung cancer is the most 
common cancer in inmates and was responsible for one in three cancer deaths in state 
prisons in 2004 (Mumola, 2007). These diseases are caused by both firsthand tobacco use 
and exposure to SHS. In the non-incarcerated population, SHS is estimated to cause 
between 57,800 to 97,700 AMIs annually and between 33,500 and 56,900 deaths from 
coronary heart disease per year (Lightwood, Coxson, Bibbins-Domingo, Williams, & 
Goldman, 2009).  
Due to the research on the physically harmful effects of cigarette smoking and 
SHS, there has been a gradual increase in the strength and number of smoke-free laws in 
communities, states, and countries. The majority of these laws prohibit smoking in indoor 
public places and/or workplaces. Local, state, and federal prisons and jails have also 
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adopted smoke-free policies, sometimes secondary to indoor smoke-free laws covering 
all state buildings. Within prison systems there is a continuum of restrictions, from 
smoke-free indoors only to tobacco-free throughout the entire prison. These policies have 
been adopted primarily because of the effects on health and health care costs from 
tobacco-related disease.  
Health of inmates and secondhand smoke exposure in prisons 
The provision of health care for inmates has been federally mandated since 1976 
when a Supreme Court ruling determined that the government has an “obligation to 
provide medical care for those whom it is punishing by incarceration”("Estelle v. 
Gamble," 1976) p. 2). Failure to do so violates the Eighth Amendment proscription 
against cruel and unusual punishment since inmates do not have the liberty of obtaining 
health care elsewhere. The key summary statement from Estelle v. Gamble that has since 
been upheld in cases brought by inmates who were exposed to SHS is that “deliberate 
indifference to serious medical needs of prisoners constitutes the unnecessary and wanton 
infliction of pain” (p. 103). In Helling v. McKinney, the Court determined that 
McKinney’s exposure to SHS by his cellmate and other inmates’ smoking posed an 
unreasonable risk to his health, both present and future that constituted “deliberate 
indifference” by prison officials to standards that society considers as decent ("Helling v 
Mckinney," 1993).   
Litigation related to SHS exposure (Sweda, 2004) plus an increasingly convincing 
body of evidence of the known harms from smoking and SHS (USDHHS, 2006) have 
provided impetus to correctional departments to adopt smoke-free or tobacco-free 
policies. The Surgeon General of the United States determined that there is no safe level 
of SHS and that separating smokers from non-smokers in indoor spaces cannot eliminate 
non-smokers’ exposure to SHS (USDHHS, 2006). The cost of health care for tobacco-
related diseases among inmates and employees, representing approximately 12% of 
prison expenditures and has been cited by correctional administrators as one of the 
primary reasons for adopting smoke-free policies (Kauffman, Ferketich, & Wewers, 
2008; Stephan, 2004). 
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Implementation of tobacco-free policies in prisons 
Smoke-free policies in prisons vary on a continuum from designated smoking 
areas indoors; to no indoor smoking with outdoor smoking allowed; to comprehensive 
smoke-free or tobacco-free policies in which smoking or all tobacco products are 
prohibited in all indoor and outdoor places. The majority of State Departments of 
Corrections and the Federal Bureau of Prisons have indoor smoke-free policies (FBOP, 
2004). Tobacco-free policies, in which no tobacco products are allowed on the grounds of 
the prison, indoors and out, are increasing in prevalence (ANRF, 2010). These tobacco-
free policies often include smokeless and spitless tobacco (e.g., snus) and sometimes also 
prohibit nicotine replacement products.  
The inherent challenge in reducing tobacco use in prisons by implementing 
tobacco-free policies is that tobacco is not only an addictive product to be smoked, 
chewed, sniffed, or placed between the lip and gum but it also is the inmates’ informal 
currency (Lankenau, 2001). Inmates are not permitted to have cash and earned income 
from working in the prison is monitored in an account managed by the prison staff and 
inmates can access it to buy goods from the prison commissary. Tobacco becomes a 
durable form of currency which is often used to barter or buy services, bribes, or other 
favors  As restrictions on tobacco use or access to the product increase with more 
restrictive prison policies, the real price of tobacco increases (Garland, 2006; Johnson, 
2010).  
The security status of the prison (minimum, medium, or maximum) may be 
related to the proportionate value of tobacco. Minimum security prisons have fewer 
physical restrictions such as barbed wire fences or guard towers, allowing greater access 
to the outside. Also, inmates in minimum security prisons frequently work away from the 
prison on work-release programs which allow greater access to tobacco even if the prison 
is ostensibly tobacco-free. Even in medium security prisons with tobacco-free policies, 
many smokers find ways to continue smoking after tobacco is officially prohibited 
(Proescholdbell, Foley, Johnson, & Malek, 2008).  
Another challenge in implementing tobacco-free prison policies and studying 
their effects is that prisons do not house a stable population of inmates compared to the 
non-incarcerated population who typically reside in the same community over time. 
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Ninety-five percent of inmates are eventually released from prison. In 2008, there were 
739,132 inmates admitted and 735,454 inmates released from state and federal prisons 
(Sabol, West, & Cooper, 2009).  
Health outcomes and smoke-free policies 
Studies with non-incarcerated populations have reported improvements in 
cardiovascular and respiratory health following passage of legislation prohibiting 
smoking in indoor public places and workplaces. The primary outcome measure in the 
literature is acute myocardial infarction (AMI), which has valid and reliable diagnostic 
criteria. Respiratory symptoms have also been measured as health outcomes but these are 
typically self-report data. Some studies have used emergency department visits for 
asthma as a proxy marker of respiratory health (Rayens, et al., 2008). To date, there have 
been no published health outcome studies of tobacco-free prison policies, although there 
have been a few air quality monitoring studies in prisons before and/or after 
implementation of these policies (McGuire & Connell, 2010; Proescholdbell, et al., 
2008). 
Study population: Kentucky Corrections Health Services Network 
The Kentucky Department of Corrections (KY DOC) is one of a few state 
systems to have partnered with a university to assist in managing the health care of its 
inmates. In 2003, the KY DOC joined with the University of Kentucky to create a public-
private partnership called the Kentucky Corrections Health Services Network (KCHSN).  
The three KCHSN partners are the KY DOC, the University of Kentucky, and 
CorrectCare Integrated Health, Inc, a for-profit health management company.  The 
KCHSN partnership established a health services network to provide medical care to 
inmates incarcerated across the state and to contain costs while at the same time 
improving quality of care. In addition, health care-related data (costs and related data on 
hospitalizations and specialty consults) are tracked electronically by CorrectCare and can 
be linked to patients, providers, and facilities. The KCHSN implemented an electronic 
health record (EHR) that allows access to the medical status, history, and medication 
record of each inmate. There is one pharmacy vendor, Diamond Pharmaceutical, for the 
 
5 
 
state that receives medication orders directly from providers via the EHR. Diamond data 
is tracked electronically and can be reported by inmate identification number, by drug, or 
disease state. This research was facilitated by having centralized databases that track the 
health care of all Kentucky inmates in state prisons. 
Purpose of the dissertation 
This dissertation research was designed to evaluate the effects of two different 
tobacco policies on respiratory and cardiovascular health indicators in Kentucky State 
prisons The overarching policy for the KY DOC prisons is an indoor smoke-free policy 
(smoking allowed outdoors) but there are five KY DOC prisons that have adopted a 
tobacco-free policy in which no tobacco products are allowed on the grounds of the 
prisons including nicotine replacement products. It was hypothesized that greater 
improvements in respiratory and cardiovascular health outcomes would occur over time 
in inmates housed in a tobacco-free prison environment than those in a prison with an 
indoor smoke-free policy. 
Overview of Chapters Two through Five 
Chapter Two is an integrative review of the evolution of smoke-free and tobacco-
free policies in correctional systems and the benefits and unintended consequences of 
these policies. Research on health outcomes following passage of smoke-free legislation 
in the non-incarcerated population is discussed. There are no studies on the effects of 
smoke-free or tobacco-free prison policies on the health of inmates. 
Chapter Three describes a time series analysis of secondary data examining the 
effects of the implementation of a tobacco-free policy on respiratory health using 
medication refills for asthma and/or COPD as a proxy marker. The purpose was to 
evaluate the effect of a tobacco-free prison policy compared to an indoor smoke-free 
policy (smoking is allowed outdoors) on the respiratory health of inmates with asthma 
and/or COPD. It was hypothesized that due to expected reductions in the rate of current 
smoking and subsequent SHS exposure in tobacco-free prisons, inmates would use fewer 
medications for asthma and/or COPD following the implementation of the tobacco-free 
policy compared to those residing in smoke-free prisons. 
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Chapter Four describes a survival analysis of secondary data that evaluates the 
hazard ratio for having an AMI in a smoke-free prison compared to a tobacco-free prison. 
It was hypothesized that there would be an increased hazard for AMI in smoke-free 
prisons versus tobacco-free prisons due to the high proportion of current smoking and 
subsequent SHS exposure. 
Chapter Five summarizes the dissertation results and discusses implications for 
practice, policy change and future research. Findings from this study will be presented to 
the KY DOC Commissioner and Medical Director and other correctional administrators.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Alison R. Connell 
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CHAPTER 2: SMOKE-FREE AND TOBACCO-FREE POLICIES IN AMERICAN 
PRISONS 
Introduction 
Over the past 20 years there has been a worldwide trend by municipalities, states 
and countries to enact smoke-free legislation. By April 2010, there were 19 states with 
100% smoke-free laws in all workplaces, restaurants and bars and nearly 400 universities 
with smoke-free policies according to the Americans for Nonsmokers' Rights (ANR, 
2010). Correctional systems, including prisons and jails, increasingly are adopting 
smoke-free policies and like many universities and hospitals are also going one step 
further to becoming tobacco-free on the entire campus both inside and outdoors. With a 
tobacco-free policy, no tobacco products are allowed on the campus, including smokeless 
tobacco products such as chew or dip and spitless products such as snus.  
The primary stimulus for smoke-free and tobacco-free policies is the harmful 
health effects of tobacco use. Tobacco use and secondhand smoke (SHS) are the leading 
causes of preventable death in the United States and the world. The World Health 
Organization (WHO) states that tobacco causes five million deaths a year and that “one in 
ten deaths worldwide” is attributable to tobacco (WHO, 2006). Smoking was calculated 
to be the cause of 512 of every 2404 deaths, or 21% of deaths in the United States in 
2000 (Peto, Lopez, Boreham, & Thun, 2006). For people who die between ages 35 and 
69 years, 28% of the deaths are caused by smoking, with an average of 23 years of life 
lost per death from smoking (Peto, et al., 2006).  
Smoking and SHS cause heart disease (USDHHS, 2006). SHS causes 80% to 
90% as much health damage as smoking (Barnoya & Glantz, 2005) and has been 
estimated to be the cause of 46,000 deaths per year in the United States (CDC, 2006) and 
58,400 acute myocardial infarctions (AMI) annually (Lightwood, et al., 2009). SHS is 
defined as a combination of sidestream smoke (from the end of a lit cigarette, cigar or 
pipe) and mainstream smoke (exhaled by the smoker) (ACS, 2010).  Even brief exposure 
to SHS from 15 minutes to 6 hours can increase the risk for cardiovascular disease by 
increasing platelet activation (Burghuber, Punzengruber, Sinzinger, Haber, & 
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Silberbauer, 1986), impairing endothelial-dependent vasodilation (Otsuka, et al., 2001), 
and lowering high density lipoprotein cholesterol levels (Moffatt, Chelland, Pecott, & 
Stamford, 2004). SHS increases the risk of AMI by 25% to 31% (He, et al., 1999). The 
overall relative risk for coronary heart disease for people who smoke is 1.78 and is 1.31 
for people exposed to SHS (Barnoya & Glantz, 2005). However, there is a dose-
dependent effect from increasing cigarette exposure as seen in a large international study, 
the INTERHEART study in 52 countries which was designed to examine cardiovascular 
risk factors for AMI including the effects of smoking and secondhand smoke on the risk 
for AMI (Teo, et al., 2006). The study enrolled 15,152 cases of first AMI matched by age 
and sex with 14,820 controls in 52 countries. The odds ratio (OR) for AMI increased by 
1.056 for every additional cigarette smoked per day so that a person who smoked 40 
cigarettes per day had an OR of 9.16. There was an increased risk of AMI with increasing 
hours of SHS exposure. The OR for having an AMI was 1.24 with 1 to 7 hours per week 
of SHS which increased to 1.62 for people living with a spouse who smoked or with 
those exposed to over 21 hours per week of SHS.  
There are multiple respiratory effects from smoking and SHS. Cigarette smoking 
is responsible for 89% of all lung cancer deaths and SHS is responsible for approximately 
3000 lung cancer deaths yearly (Peto, et al., 2006). Cigarette smoking and SHS cause 
airway obstruction through bronchoconstriction, inflammation and airway remodeling 
(Flouris, Vardavas, Metsios, Tsatsakis, & Koutedakis, 2010). SHS of one hour duration 
decreases lung function as evidenced by a reduction in forced expiratory volume in one 
second (FEV1) (Flouris, et al., 2009).  
Inmates have higher rates of current smoking than the non-incarcerated 
population with rates ranging from 42 to 91 % with an average of 70-74% prevalence 
which results in high secondhand smoke exposure for nonsmoking inmates and staff 
(Cropsey, Eldridge, Weaver, Villalobos, & Stitzer, 2006; Durrah, 2005). A survey of 388 
male inmates in a Kentucky state prison found that 71.4% were current smokers (defined 
as smoking every day or some days) and 85.8% reported having smoked at least 100 
cigarettes in their life (Connell, Winter, & Curd, 2007). This is similar to the 73.9% rate 
of current smokers in a female Mississippi prison (Cropsey, Eldridge, & Ladner, 2004). 
Kentucky and Mississippi may have higher proportions of inmates who smoke since there 
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is a greater prevalence of current smokers in those states (25.6% and 23.3% respectively) 
(BRFSS, 2009; MMWR, 2009). This compares to a smoking prevalence of  20.6 % 
among adults in the United States in 2008 and 2009 who are current smokers according 
to the Centers for Disease Control and Prevention (CDC, 2010; MMWR, 2009). Even in 
California which has a 14% prevalence of current smoking in the general population, 
approximately 50% of inmates smoke (Gardiner, 2005).  
This paper reviews the current literature on smoke-free and tobacco-free policies 
in correctional systems, primarily at the state and federal levels. The first section explains 
the difference between smoke-free and tobacco-free policies and the evolution of smoke-
free to tobacco free policies in correctional systems. The second section discusses the 
health outcomes of smoke-free policies and potential health benefits in the incarcerated 
population. The third section describes litigation surrounding the use of tobacco in 
prisons and the unintended consequences of smoke-free and tobacco-free policies in 
incarcerated populations. Finally, implications for research on outcomes of the tobacco-
free policies in the prisons will be presented. A search of the current literature was 
performed using the key words: smoke-free policy, tobacco-free policy, secondhand 
smoke, prison, and inmates, in the Web of Science, PubMed, the Bureau of Justice 
Statistics, and on state Departments of Corrections websites for specific laws and 
policies.  
The evolution of smoke-free and tobacco-free policies in correctional systems 
Smoke-free laws or policies enacted by municipalities, states, and adopted by 
correctional facilities typically require that there is no tobacco smoking indoors and also 
within a certain distance of entrances, windows, and vents. There are increasing numbers 
of municipalities that are also limiting outdoor smoking in public places such as cafes, 
bus stops, sports arenas, parks and sidewalks (ANR, 2010). Institutions such as 
universities, hospitals and prison systems are also adopting tobacco-free policies in which 
no tobacco products are allowed on the facility’s campus such as the University of 
Kentucky in November, 2009 (University of Kentucky Tobacco Policy, 2009). 
Smoke-free policies vary among correctional systems in comprehensiveness of 
the scope of the policy. Smoke-free policies in prisons usually mean that smoking is not 
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allowed indoors. Depending on the state, this may apply to inmates and staff or just 
inmates. In some correctional systems, smoke-free means that there is no smoking 
indoors but there are designated outdoor or covered outdoor smoking areas for staff 
and/or inmates such as in the Federal Bureau of Prisons (FBOP) (FBOP, 2004). Indiana 
implemented a smoke-free policy in 1997 in which no lit tobacco was  allowed on the 
grounds of the prison and cigarettes were no longer sold in the commissary (Cropsey & 
Kristeller, 2003). The three primary reasons for adopting smoke-free policies cited by 
State Departments of Corrections administrators are to reduce health care costs while 
improving the health of employees and inmates, avoid litigation, and comply with 
pending or current laws limiting smoking in state-owned facilities (Kauffman, et al., 
2008; Patrick & Marsh, 2001). However, indoor smoke-free policies in prisons where the 
majority of inmates still smoke outdoors expose non-smokers to SHS. The 2006 U.S. 
Surgeon General Report states that there is no risk-free level of SHS and that simply 
separating smokers from nonsmokers does not protect them from the effects of SHS 
(USDHHS, 2006). 
Tobacco-free policies in prisons are stricter and disallow any form of tobacco on 
the prison grounds. Under these policies tobacco is considered contraband similar to 
illicit drugs such as heroin for staff and inmates. The exposure to SHS by non-smokers 
and the health costs secondary to smoking by inmates and staff have been the primary 
motivators for prisons to become tobacco-free. A warden in Kentucky expressed concern 
that it was morally and fiscally irresponsible to sell cigarettes to pregnant women, 
asthmatics or people with heart problems (Lamb, 2007). Providing health care to inmates 
is federally mandated and is costly, which adds an extra stimulus to eliminate tobacco in 
prisons to reduce morbidity and associated costs. Inmates are the only sub-population 
group in the United States who are mandated to receive health care by the Supreme Court 
which determined that refusing health care to inmates could be considered cruel and 
unusual punishment ("Estelle v. Gamble," 1976). The cost of health care for all state 
prisons in 2001 was $3.29 billion or 12% of prison operating costs (Stephan, 2004).  
There has been a gradual transition in correctional systems from allowing smoke 
in the entire prison, to indoor smoke-free policies followed by more comprehensive 
smoke-free and tobacco-free policies which have become increasingly more prevalent in 
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recent years. Since the early 1990s, there has been an increase in the number of indoor 
smoke-free policies in state and federal correctional systems. The American Correctional 
Association (ACA) and the American Jail Association adopted resolutions in 1990 
supporting non-smoking policies (Vaughn & del Carmen, 1993). The ACA reinforced 
their support in 1999, 2004 and 2009 by ratifying the “Public Correctional Policy on 
Nonsmoking Policies” which recommended non-smoking policies to improve the health 
of staff and inmates, decrease medical expenses, and improve fire safety (ACA, 2009). 
The National Commission on Correctional Health Care (NCCHC) Standard for Health 
Services on the use of tobacco in prisons and jails recommends no smoking inside, 
designated outside smoking areas, and availability of nicotine replacement products 
(NCCHC, 2003).  
In 1992, there were no prisons or prison systems that prohibited smoking entirely, 
but six (12%) state correctional systems designated some cellblocks as non-smoking 
(Vaughn & del Carmen, 1993). Twenty states’ administrators reported that the only 
inmates who were provided with smoke-free cells were those with pre-existing medical 
conditions that could be worsened by SHS exposure. Since there were only six states with 
some smoke-free cellblocks, these inmates would still have been exposed to SHS from 
neighboring cells. Five states reported that all inmates were provided a smoke-free 
environment when it was requested. There were 16 states at that time in which no inmates 
had smoke-free environments (Vaughn & del Carmen, 1993).  
The number and strength of smoke-free policies in prisons has increased 
gradually. A 1996 survey of all 50 states’ departments of corrections, the District of 
Columbia and the Federal Bureau of Prisons reported that seven prison systems had 
implemented smoke-free policies and 44 had limited indoor smoking in certain areas 
(Patrick & Marsh, 2001). By 2002, 38 of 50 states had indoor smoking prohibitions or 
limited indoor smoking (Zoroya, 2004). In 2004, the Federal Bureau of Prisons (FBOP) 
prohibited lit tobacco products in all of its 105 prisons which house 180,000 inmates 
(FBOP, 2004).  
Smoke-free prison policies when limited to indoor areas do not reduce the rate of 
current smoking, exposing non-smokers to SHS. With most indoor smoke-free policies 
tobacco is still sold in the prison commissary and is used as currency between inmates 
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and sometimes creates a barter system between staff and inmates (Lankenau, 2001). 
There are drawbacks to indoor-only smoke-free policies in prisons. One, the majority of 
inmates can continue to smoke unless the entire prison is smoke-free. When the entire 
prison is smoke-free and inmates are disciplined for visible smoking, there is more 
incentive to smoke in the cells exposing others to SHS. There is also a risk of fire from 
smoking paraphernalia which has led some state systems to also prohibit the use or sale 
of matches in canteens.  
Tobacco-free policies in prisons restrict any form of tobacco being brought into 
the prison, sold in the canteen, or in vehicles on the grounds of the prison. Tobacco on the 
premises is considered contraband for staff and inmates which in some states is a 
misdemeanor and in others carries a felony penalty. This includes smokeless and spitless 
tobacco, including snuff and snus. Some prison systems continue to allow nicotine 
replacement therapy (NRT) products to be sold in the commissary and some do not. 
California and South Carolina did not allow NRT because nicotine gum can be made into 
a mold to make keys and disable locks (Gardiner, 2005; Polito, 2009) and nicotine 
patches can be dried and smoked (Polito, 2009).  
Correctional facilities in the District of Columbia became tobacco-free on August 
1, 2004 (Corrections, 2004). California’s correctional systems became tobacco-free with 
the passage of Assembly Bill 384 on July 1, 2005 which prohibits the use, sale and 
possession of tobacco products by inmates and prison employees (Gardiner, 2005). By 
2005, seven states had tobacco-free policies in their prisons (Colorado, Delaware, Idaho, 
Indiana, Maine, Minnesota, and Nebraska) (Gardiner, 2005). A 2007 survey of the 50 
states, the District of Columbia and the Federal Bureau of Prisons reported that 31 (60%) 
had tobacco-free policies but most of these refer to indoor smoke-free policies as opposed 
to completely tobacco-free prison policies (Kauffman, et al., 2008). By April 2010, nine 
State Departments of Corrections’ prisons had tobacco-free prison policies and four more 
are poised to become tobacco-free in 2010 including Nevada, Virginia, North Carolina, 
and Georgia (Gardner, 2009; Mower, 2009; Sheinin, 2009). In some states, there is not 
one policy that covers all prisons as in Kentucky where the overarching policy for all 
prisons is smoke-free indoors with smoking allowed outside but five of the 16 state 
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prisons also have tobacco-free campuses in which no tobacco is allowed on the prison 
grounds (Adams, B. personal correspondence, March 12, 2009).  
Health outcomes of smoke-free policies in the non-incarcerated population 
The health benefits of smoke-free legislation affecting the non-incarcerated 
population have been documented primarily in the reduction of cardiovascular and 
respiratory diseases. The Institute of Medicine (IOM) concluded in 2009 that there was 
sufficient evidence to infer a causal relationship between low levels of SHS and coronary 
heart disease and that smoke-free policies reduce the risk for AMI (IOM, 2009). The 
CDC recommends that people with heart disease avoid SHS (USDHHS, 2006). The 
incidence of acute myocardial infarction (AMI) is the most commonly used policy 
outcome measure. AMI as an outcome variable has the benefit of having distinct, 
measurable diagnostic criteria as opposed to a respiratory outcome which is usually 
measured by subjective reports of symptoms such as rhinorrhea, shortness of breath or 
cough.   
The impact of city, state and national smoke-free legislation on the reduction of 
AMIs has been widely studied. The first report on AMI incidence was from Helena, 
Montana after enactment of a smoke-free ordinance in 2002 which was followed by a 
40% reduction in AMIs over the next six months compared to the same six months the 
year before (Sargent, Shepard, & Glantz, 2004). A time-series analysis using the 18 
month period before and after an ordinance was implemented in Pueblo, Colorado found 
a 27% reduction in AMI hospitalizations in the City of Pueblo and no decrease in the 
adjacent county where public smoking was allowed (Bartecchi, et al., 2006). New York 
State passed a comprehensive smoke-free law in 2003. In the following year there were 
3,813 fewer hospital admissions (8% reduction) for AMI than expected after adjusting for 
seasonal and secular trends (Juster, et al., 2007).  
Reductions in AMI have also been reported after entire countries enacted indoor 
smoke-free laws. The hospitalization rate for AMIs in a region of Italy decreased by 11% 
among people younger than age 60 after a prohibition on indoor smoking in public places 
in 2005 (Barone-Adesi, Vizzini, Merletti, & Richiardi, 2006). There was a 17% reduction 
in the risk for AMI in a meta-analysis of 11 studies from 10 locations worldwide where 
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smoke-free laws were enacted (Meyers, Neuberger, & He, 2009). A meta-analysis of 
studies on AMI hospitalizations found a pooled risk estimate of 0.83 following smoke-
free policy enactment with the relative risk reduced to 0.64 after three years of follow-up 
(Lightwood & Glantz, 2009).  
In addition to improvements in cardiac health, the implementation of a smoke-free 
ordinance was associated with reductions in emergency department visits for asthma and 
respiratory symptoms. In Lexington, Kentucky in the 32 months after passage of a 
smoke-free law prohibiting smoking in most indoor public places there was an overall 
22% reduction of emergency department visits (p <.001; confidence interval (CI) 14% to 
29%) compared to the 40 months prior to the law (Rayens, et al., 2008). Bar workers in 
Perthshire, Scotland reported a decrease in respiratory symptoms within one month of a 
smoke-free law (p < .001) (Menzies, et al., 2006). Fifteen of the 105 bar workers had 
asthma. The FEV1 in the entire cohort increased by 8.2% after one month (CI 3.9-12.4, p 
< .001) and by 15.7% in those with asthma (CI 5.7-25.7, p = .008). 
In the non-incarcerated population where smoke-free policies do not restrict 
individuals from smoking in private locations such as homes and cars, there have been 
reductions in health care costs and in the proportion of current smokers. In New York 
State after a comprehensive smoke-free law was passed in 2004, fewer hospital 
admissions for AMI resulted in direct health care cost savings of $56 million (Juster, et 
al., 2007). In the 20 months after the passage of a smoke-free ordinance in Lexington, 
Kentucky there was a 32% decrease in current adult smokers, with no change in the 
percent of smokers in comparable counties, resulting in an estimated $21 million in 
healthcare cost savings per year (Hahn, et al., 2008).  
After passage of smoke-free legislation there are lower levels of ambient SHS. 
Particulate matter (PM2.5) which measures fine particle pollution such as SHS has a 
National Ambient Air Quality Standard (NAAQS) for outdoor air for 24 hours  of 35 
micrograms per cubic meter (µg/m3) (EPA, 2009). PM2.5 was measured in eight 
restaurants and a bowling alley before and after smoke-free legislation was passed with 
levels decreasing by 79% one week after implementation of the law (Lee, Hahn, Riker, 
Head, & Seithers, 2007). Comprehensive smoke-free laws result in greater decreases in 
PM2.5 than partial smoke-free laws which encompass some but not all public venues.  
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PM2.5  levels dropped by 88% from a mean of 161 µg/m3 to 20 µg/m3 in communities 
with comprehensive smoke-free laws. However, levels varied dramatically based on the 
type of venue in communities with a partial law: bars which were exempt had an average 
of 235 µg/m3 in bars, while restaurants which were covered under the law had an average 
of 10 µg/m3 (Lee, et al., 2009). 
Potential health benefits of comprehensive smoke-free and tobacco-free policies in 
prisons 
Consistent with the high rates of smoking among inmates, the prevalence of 
tobacco-associated disease burden is high. The leading cause of death in state prison 
inmates is heart disease, accounting for 27% of the deaths in state prisons between 2001 
and 2004 (Mumola, 2007). A study of the deaths in the Cook County Jail in Chicago, IL, 
from 1994 to 2004 showed that heart disease was the number one cause of death with an 
age-adjusted mortality rate of 312.1 per 100,000 per year compared to the national 
average in the non-incarcerated population of 240.8 per 100,000 per year (Kim, et al., 
2007). Using data from a self-report survey of jail inmates in 2002 and of state and 
federal inmates in 2004, the prevalence of hypertension was between 27.9% in jail 
inmates and 29.5% in federal inmates, compared to the U.S prevalence of 25.6% (Wilper, 
et al., 2009). The proportion of those with asthma was 7.7% for federal inmates and 9.8% 
for state inmates compared to 7.5% for the U.S non-incarcerated population (Wilper, et 
al., 2009). Cancer is the second leading cause of death in state prison inmates, with lung 
cancer accounting for a third of the cancer deaths (Mumola, 2007).  
The cost of treating chronic and acute diseases in inmates continues to climb each 
year. In 2001 the cost for health care in the 50 state prison systems was $3.3 billion, 
accounting for 12% of the total operating cost (Stephan, 2004). Kentucky Department of 
Corrections reported that the highest medical cost by category was for the treatment of 
diseases of the circulatory system which cost $3.4 million in the 10 months from July 1, 
2008 to April 30, 2009 (Upton & Spaulding, 2009). Georgia spends $226 million per year 
or 17% of its budget on health care (Sheinin, 2009). As the population ages it is 
anticipated that health care costs will continue to climb. The cost of tobacco use in prison 
inmates has not been estimated for all states or the federal prison system. In 1999, the 
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California Department of Health Services estimated the cost of tobacco use among 
inmates as $3,331 per smoker per year (TEROC, 2003).   
Most States’ Departments of Corrections cite improvements in health and 
reductions in health care costs as the primary motivators for implementing tobacco-free 
policies; however there are no published data on the health outcomes or health care cost 
savings of smoke-free or tobacco-free policies in prisons. Based on studies in the non-
incarcerated population, reductions in the proportion of current smokers and cigarettes 
consumed would be anticipated to provide health benefits with improvements in 
cardiovascular and respiratory health. The Lightwood and Glantz (2009) study which 
estimated a relative risk of 0.83 for having an AMI one year after smoke-free legislation 
in public places was passed, assumed that only 23% of the population were current 
smokers and that there was a relative reduction of cigarettes smoked by 29% using data 
from a previous study showing that 3.8% of current smokers quit after a smoke-free 
workplace law was enacted and the ones who continued to smoke smoked an average of 
3.1 fewer cigarettes per day (Fichtenberg & Glantz, 2002). Given that inmates as a sub-
population group have excessively high rates of tobacco use with an average of 70% 
current smokers, subsequent reductions in current smoking, tobacco use, and SHS 
exposure following a tobacco-free policy would be expected to have greater 
improvements in health than prisons with indoor smoke-free policies.  
Reductions in current smoking and cigarette consumption have been reported in 
prisons that have adopted comprehensive (indoors and outdoors) smoke-free policies and 
tobacco-free policies (Cropsey & Kristeller, 2005b; Proescholdbell, et al., 2008). The 
reductions vary by the comprehensiveness of the policy and by the security status of the 
prison. After adoption of a comprehensive indoor and outdoor smoke-free policy in the 
Indiana DOC where no cigarettes were sold in the canteen, 76% of current smokers 
reported that they continued to smoke one month after the date of the policy 
implementation (Cropsey & Kristeller, 2005a). Inmates were surveyed in two prisons, 
one of which had a tobacco-free policy and one with a tobacco-free indoor policy, and 
reported a higher prevalence of current smoking in the prison with the partial policy 
(64%) than inmates in the prison with a complete tobacco-free policy (42%). In a 
qualitative survey of 140 inmates and 50 staff from 10 jails and six prisons in eight states, 
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inmates reported that in prisons with a lower security status (i.e. minimum security or 
work release), there was greater ease of violating a tobacco-free policy than in higher 
security prisons. Maximum security prisons had the least tobacco smuggled into the 
prison (Lankenau, 2001).  
Litigation related to tobacco use in prisons 
Litigation has been a driving force in prompting smoke-free policies in the 
corrections environment. The most prominent court case that went to the U.S. Supreme 
Court was in 1993 when a non-smoking inmate charged that his cell-mate smoked five 
packs a day, causing the plaintiff’s current and future health problems ("Helling v 
Mckinney," 1993). The Court upheld the plaintiff’s claim of health damage from SHS, 
citing the Eighth Amendment which bars criminals from infliction of cruel and unusual 
punishment. The court ruling referred to the case of Estelle v. Gamble ("Estelle v. 
Gamble," 1976) which stated “that deliberate indifference to serious medical needs of 
prisoners” constitutes an Eighth Amendment violation (p.103).  This judicial ruling set 
the precedent for inmates to receive a standard of medical care, the denial of which would 
“result in pain and suffering which no one suggests would serve any penological 
purpose” (p. 103). A lawsuit in Wisconsin by an inmate with severe chronic asthma 
claimed that the warden and other prison staff acted with deliberate indifference in 
allowing prisoners to smoke in violation of prison policy (Sweda, 2004). The Court of 
Appeals upheld his case stating that his health was being endangered by SHS exposure. 
An asthmatic inmate was awarded $54,750 in compensatory and punitive damages 
because he had been denied a smoke-free cell for five years ("Reilly v. Grayson," 2001).  
However, in lower courts, the standard of Helling v. McKinney has not always 
been maintained (Wilcox, 2007a). In Michigan in 2003, the court ruled that the potential 
health hazards from SHS did not represent a sufficiently serious medical risk and there 
was not deliberate indifference because the prison had adopted an indoor non-smoking 
policy ("Henderson v. Martin," 2003). The Eleventh Circuit ruled against an inmate’s 
claim that SHS exposure was harmful citing lack of evidence of unreasonable high SHS 
levels ("Kelley v. Hicks," 2005). 
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Litigation opposing smoke-free policies has also been brought against state 
departments of corrections.  In 1997, eight lawsuits were dismissed by the Massachusetts 
Superior Court which alleged that smoke-free policies violated inmates’ Eighth 
Amendment rights and “amounted to intentional infliction of emotional distress” (Young, 
2002). The smoke-free policy that was being contested was originally implemented as a 
result of a class-action lawsuit from non-smoking inmates who were concerned about 
SHS exposure.  
In some Western states, American Indians have been allowed to use tobacco in 
religious ceremonies. However, in South Dakota this policy was reversed by the Director 
of Prison Operations because tobacco was too addictive to be used for ceremonies and 
was being abused and traded (Hult, 2009). This is currently being challenged by the 
Native American Council of Tribes.  
Unintended consequences of tobacco-free policies in correctional systems 
While there are potential benefits of tobacco-free policies in prisons there may 
also be unintended consequences which impede the transition to tobacco-free prison 
systems including: decreased revenue from tobacco sales, enforcement issues, tobacco as 
contraband, and concerns about inmate tension and behavior disruption. The State of 
California reported that in 2003 tobacco sales by inmates generated $1 million in tobacco 
taxes and $370,000 in sales tax which was lost after the state prisons became tobacco-free 
(Gardiner, 2005). This report suggested that there would be an estimated $280 million in 
savings in health care costs but this was derived by calculating the approximate health 
care costs from tobacco use per inmate times the estimated number of current smokers 
and subtracting that amount from the state healthcare budget. This is not an accurate 
estimation since inmates may have permanent health damage from tobacco use and the 
effects of quitting are not immediate.  
Enforcement of smoke-free and tobacco-free policies in prisons varies by prison 
staff and among and within prisons. The biggest problem with enforcement is that 
tobacco is the primary black market currency in prisons and becomes more valuable with 
increased restrictions on its use (Lankenau, 2001). Inmates earn an average of 0.50¢ to $1 
a day which is deposited in the prison accounts and used to buy food, snacks, hygiene 
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products and cigarettes if available at the prison canteen. Since money is not available for 
currency and the majority of inmates are current smokers, loose tobacco and rolled 
cigarettes are the currency for buying services, goods, and favors. Lankenau (2001)  
surveyed 140 inmates and 50 staff and officers in 2000 about tobacco use in prisons with 
smoke-free and tobacco-free policies and reported that inmates have elaborate 
mechanisms for getting tobacco into the prisons, selling it and smoking it. A “mule” who 
smuggles the tobacco into the facility may be an officer, another inmate on community 
work-duty or a community service worker. The officers who participate in the tobacco 
black market can charge between $20 and $50 per pack of cigarettes and could earn an 
entire week’s pay from one tobacco or cigarette transaction. The inmate then sells the 
cigarettes for $200 to $500 per carton..  
Once prisons become tobacco-free as opposed to being smoke-free or having an 
indoor smoke-free policy, tobacco becomes an even higher prized commodity which has 
been reported to overtake heroin as the number one smuggled contraband item (NCCHC, 
2004). The Maryland DOC reported that tobacco has become the leading smuggled item 
and that a can of loose tobacco can sell for $1,000 (Garland, 2005). In Ohio, a year after 
the prisons became tobacco-free, a can of loose tobacco sold for $300 and a cigarette for 
$10 (Johnson, 2010). In response to this trend, some states (i.e., New York and Texas) 
consider smuggling tobacco into prisons a felony (Byrne, 2006). Once prisons become 
tobacco-free, chips, candy or other items from the commissary may become currency as a 
substitute for tobacco (Sheinin, 2009). 
Enforcement may be hampered by the security status of the prison or by the 
comprehensiveness of the policy. Minimum security prisons are relatively loosely 
guarded allowing inmates to have more opportunities for contact with the non-
incarcerated population. Many medium security prisons have a minimum security 
dormitory outside the fenced area for low-risk inmates who do maintenance or work in 
the community on road crews. The more access the inmate has to the outside, the easier it 
is to smuggle tobacco in to the prison (Lankenau, 2001). Indoor smoke-free policies are 
hard to enforce because inmates may smoke in their cells at night and unless the smoking 
is seen, it cannot be cited. Prisons that have indoor and outdoor smoke-free policies are 
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also hard to enforce because there are many ways of hiding the tobacco, the smoke, and 
the lighting paraphernalia.  
Variations in the enforcement of smoke-free and tobacco-free policies were found 
in a study of air quality at four prisons in Kentucky (Unpublished, McGuire, & Connell, 
2010). Four prisons were chosen as study sites: two of which had indoor smoke-free 
policies (outdoor smoke allowed) and two of which had tobacco-free policies (no tobacco 
on campus). Fine particulate matter (PM2.5) was measured for two hours in two 
dormitories at each prison (see Table 2.1). At the two prisons with smoke-free policies in 
two medium security dormitories, the maximum PM2.5 over the two hour period was 37.1 
and 37.5µg/m3, while the minimum security dormitories in those prisons had PM2.5 of 
17.4 and 16.5 µg/m3. At the two prisons with tobacco-free policies there were variations 
in PM2.5between dormitories. At one tobacco-free prison the maximum PM2.5 was 15.0 
µg/m3 in a medium security dormitory compared to 4.1 µg/m3 in the minimum security 
dormitory. At the other tobacco-free prison, which was entirely minimum security, one 
dormitory had a maximum PM2.5 of 30.4 µg/m3 while another dormitory in the same 
prison had a maximum PM2.5 of 11.2 µg/m3 showing a possible difference in enforcement 
of the policy even within one prison with the same security status (see Table 2.1). 
Enforcement may not be the only reason for the difference in PM2.5 levels. Inmates in a 
minimum security dormitory may not want to risk a disciplinary violation which might 
result in loss of privileges, time for good behavior or having to go back into the medium 
security area “behind the fence” rather than the relative freedom of minimum security. A 
study in North Carolina reported that there was a 98% decrease in PM2.5  from 305 µg/m3 
before to 6.5µg/m3 in a dormitory after a comprehensive tobacco-free policy was 
implemented (Proescholdbell, et al., 2008). 
Another unintended consequence of tobacco-free policies in prisons is the 
incidence of behavior disturbances among inmates. In Georgia at the Lee Correctional 
Institution in Leesburg there were about 150 inmates who refused to work after an indoor 
smoke-free policy was implemented (Sheinin, 2009).  However, the NCCHC and the 
National Network on Tobacco Prevention and Poverty surveyed 100 prison and jail 
administrators and juvenile detention facilities in 2000 (NCCHC, 2004) and reported few 
incidents of behavior problems in prisons that adopt smoke-free or tobacco-free policies.  
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Policy analysis implications 
The results of policy analysis studies following passage of smoke-free laws in the 
non-incarcerated world may not be generalized to prison settings. Prisons have some 
similarities with the non-incarcerated population but have much dissimilarity. In the non-
incarcerated population when there is an indoor smoke-free law, an individual has the 
ability and the right to smoke in his or her car, house, or land but may not in indoor 
public places or workplaces. In a prison with a comprehensive smoke-free policy or in a 
tobacco-free prison, the inmate loses the right to smoke and the only option is to partake 
in illicit activity to smoke. This may result in a greater decrease in current smoking rates 
than the non-incarcerated population. There are also varying strengths of smoke-free 
policies and variations in enforcement of either smoke-free or tobacco-free policies 
among and within prisons, which create challenges in determining the effect of these 
policies on health outcomes. 
The health benefits of smoke-free policies have been studied in communities, 
states, and countries and significant benefits in cardiovascular and respiratory health have 
been documented. However, there are unique challenges that are specific to the 
corrections community that impact the health outcomes of tobacco policies. One of the 
primary challenges in studying the health outcomes of policy initiatives in prisons is the 
transient nature of the inmate population, with as many inmates discharged each year as 
are committed. For example, in 2008 the Kentucky Department of Corrections admitted 
14,426 offenders and released 15,642 offenders but had an average population of 21,700 
at any given point in time (Adams, B., personal communication, March 23, 2009).  
Inmates move fairly frequently between prisons or jails and some of the prisons may be 
tobacco-free while others have indoor smoke-free policies where outdoor smoking is 
allowed. Thus, the exposure to the policy by individual inmates becomes hard to 
quantify.  
The long-term effect of a tobacco-free policy is difficult to measure. The majority 
of inmates who are housed in a tobacco-free environment return to smoking once moved 
to an environment that allows smoking or when discharged, and the health benefits from 
tobacco-free policies may not be sustained (Cropsey & Kristeller, 2005a). When inmates 
are discharged they are usually lost to follow-up precluding long-term follow-up. 
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Research that examines the effect of a tobacco-free policy on immediate or short-
term health outcomes such as respiratory symptoms or physiologic measures like FEV1 
may be able to minimize the attrition of a long-term study. In prisons that are becoming 
tobacco-free, a pre-post-design could be conducted which measures salivary cotinine 
levels before and after implementation. Surveying inmates on their personal use of 
tobacco in a tobacco-free prison is hindered by the disciplinary consequences associated 
with violating prison policy.  
Cost as an outcome measure of the effect of tobacco-free policies in prisons is 
difficult to track in prisons. Health care costs continue to rise and the inmate population is 
aging which increases health care costs. However, costs may stabilize or decrease as the 
prison population shrinks due to changes in sentencing laws and parole rules designed to 
reduce the prison population. The prison population increased by 0.8% in 2008 which is 
the slowest rate since 2000 so the costs may stabilize based on these changes and not on 
the tobacco policy (Sabol, et al., 2009).  
Conclusions 
The general movement toward smoke-free legislation is a relatively recent trend 
in local communities, states and countries. Correctional systems are also adopting 
policies that vary in scope from restricting smoking indoors, to complete smoking 
prohibition indoors and out, to tobacco-free prisons in which all tobacco products are 
considered contraband for staff and inmates. This trend has been prompted by the need to 
reduce health care costs, morbidity, and mortality among inmates and staff. It also may 
be secondary to litigation by inmates who are increasingly concerned about exposure to 
SHS. National and international research continues to show the benefits of reducing SHS 
exposure, and the widely accepted knowledge that there is no safe level of SHS 
(USDHHS, 2006). Improving the health of inmates is an important public health issue 
since there are currently 7.3 million people in the United States who are under some form 
of correctional supervision including probation, parole, jails, state and federal prisons 
(Glaze & Bonzcar, 2009). 
Studies in prisons mirror the results from community-based studies in that the 
strength and enforcement of the tobacco-related policy determine the reduction in SHS 
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and current smoking. Indoor smoke-free policies do not reduce current smoking 
prevalence which in inmates is, on average, more than three times the proportion of 
current smokers in the United States (Connell, et al., 2007). Variations in enforcement of 
indoor smoke-free policies may result in high indoor SHS. Comprehensive smoke-free 
prison policies and tobacco-free policies have been associated with reductions in cigarette 
consumption. However, even in prisons that have adopted complete smoke-free and 
tobacco-free policies, tobacco is smuggled in to the prison and many inmates continue to 
smoke especially in prisons with low security status.  
 Comprehensive smoke-free (indoors and out) and tobacco-free policies in prisons 
may result in improvements in the health of inmates and correctional staff including 
lower rates of coronary heart disease, AMIs, and asthma exacerbations. Subsequent 
reductions in health care costs have been reported in the non-incarcerated population 
following enactment of smoke-free legislation. Research on health outcomes after prisons 
adopt smoke-free or tobacco-free policies has not been reported in the literature. 
There are unintended consequences of tobacco-free policies in the correctional 
system such as reduced canteen sales and varied enforcement levels within and among 
correctional officers and prisons. Tobacco may become a primary contraband item to be 
smuggled into the prison which in some cases is a misdemeanor but in Texas has been 
reclassified as a felony due to the number of employees smuggling tobacco (Wilcox, 
2007b). Concerns about inmate tension following a tobacco-free policy have occurred but 
are minimal.  
In spite of continued illicit smoking by some inmates and variations in 
enforcement, it is anticipated that tobacco-free policies will produce declines in AMI 
incidence and improvements in lung function and decrease health care costs primarily 
due to the health benefits from reductions in cigarette consumption and SHS exposure. 
Reducing health risks by implementing and enforcing a tobacco-free prison policy during 
incarceration for the revolving population of approximately 1.64 million people in state 
and federal prisons may improve the health of a portion of the population that has high 
risk factors for cardiovascular and respiratory diseases. If improvements in health and 
reductions in health care costs are goals for correctional policy makers and 
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administrators, comprehensive tobacco-free policies with strict enforcement are more 
likely to achieve that goal.  
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Table 2.1 Measurements of particulate matter (PM2.5) in prisons with indoor smoke-free 
and tobacco-free policies (N = 4) 
 
 Security status 
of dormitory  
Highest level of 
PM2.5 µg/m3  
Security status 
of dormitory  
Highest level of 
PM2.5 µg/m3 
EKCC (Indoor 
smoke-free)  
Medium 37.1 Minimum 17.4 
LSCC (Indoor 
smoke-free) 
Medium 37.5 Minimum 16.5 
BCC  
(Tobacco-free) 
Medium 15.0 Minimum 4.1 
KCIW  
(Tobacco-free) 
Minimum 30.4 Minimum 11.2 
(McGuire and Connell, unpublished, 2010)  
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CHAPTER 3: TOBACCO-FREE PRISON POLICIES AND RESPIRATORY HEALTH 
AMONG INMATES 
Synopsis 
Purpose: The purpose of this study was to evaluate the effect of a tobacco-free 
prison policy compared to an indoor smoke-free policy on the respiratory health of 
inmates who have asthma and/or COPD.  
Hypothesis: It was hypothesized that due to reductions in the rate of current 
smoking and subsequent SHS in tobacco-free prisons, inmates in these prisons would use 
fewer medications for asthma and/or COPD compared to inmates with asthma and/or 
COPD in prisons that were not completely tobacco-free. 
Method: This study was a multivariate time series analysis to evaluate the effect 
of tobacco-free policies in two state prisons on the respiratory health of inmates with 
asthma and/or COPD compared to inmates with asthma/COPD who were incarcerated at 
two state prisons designated as smoke-free (smoke-free indoors, with smoking allowed 
outdoors). Medications for asthma and/or COPD including oral medications and inhalers 
were used as proxy markers for respiratory health. 
Results: There was an immediate effect of the tobacco-free policy on the use of 
short-term inhalers such as albuterol and ipratropium within a month after the policy was 
implemented. However, the rate of use gradually increased to the level prior to the policy 
implementation within 12 to 15 months at the tobacco-free prisons. The rate of refills of 
long-acting inhalers had opposite trends before and after implementation of the tobacco-
free policy. There was no effect of the policy intervention on the use of oral medications 
but there may have been a prescribing effect by the primary care providers with 
differences in the use of certain medications in the four prisons. 
Conclusion: Although there was an immediate reduction in short-acting inhaler 
use the effect was not sustained which may be reflective of the rapid turnover in the two 
tobacco-free prisons or the minimum security status which may facilitate tobacco use by 
inmates due to fewer physical restrictions in the prison setting.   
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TOBACCO-FREE PRISON POLICIES AND RESPIRATORY HEALTH AMONG 
INMATES 
Introduction 
Cigarette smoking is the leading cause of preventable death in the world, killing 
50% of smokers, according to the World Health Organization (WHO) (WHO, 2006). 
Almost all lung cancer deaths (89%) and 34% of all cancer deaths are attributed to 
smoking (Peto, et al., 2006). Smoking related damage to the respiratory system results in 
increased risks for chronic obstructive pulmonary disease (COPD), chronic bronchitis, 
asthma and upper airway infections (Trupin, et al., 2003). Secondhand smoke (SHS) 
causes 80% to 90% as much health damage as smoking (Barnoya & Glantz, 2005) and 
has been estimated to be the cause of  approximately 3400 lung cancer deaths per year 
(Peto, et al., 2006). The 2006 U.S. Surgeon General’s report reviewed the scientific 
evidence to date and concluded that there is no risk-free level of exposure to SHS and 
that separate smoking areas within a building cannot eliminate SHS. Secondhand smoke 
is defined by the American Cancer Society (ACS) as a combination of sidestream smoke 
which is the smoke from the end of a lighted cigarette, cigar or pipe, and mainstream 
smoke which is the smoke exhaled by the smoker (ACS, 2010). 
Prison inmates have a higher prevalence of current smoking than the non-
incarcerated population with rates from 42 to 91 percent (average of 70-74%) (Connell, et 
al., 2007; Cropsey, et al., 2006; Durrah, 2005) compared to 20.6 percent in the U.S. 
(CDC, 2010; MMWR, 2009). The Centers for Disease Control and Prevention (CDC) 
defines a current smoker as having smoked at least 100 cigarettes in one’s life and 
smoking every day or some days in the past 30 days.  
Consistent with the high rates of smoking among inmates, the prevalence of 
tobacco-associated respiratory disease burden is high. Cancer is the second leading cause 
of death in state prison inmates with lung cancer accounting for a third of the cancer 
deaths, similar to the U.S. non-incarcerated population (Mumola, 2007). The proportion 
of people with asthma was 7.7% for federal inmates and 9.8% for state inmates compared 
to 7.5% for the U.S non-incarcerated population (Wilper, et al., 2009). It is important to 
note that these estimates are based on self-report which are not always reliable.  
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Cigarette smoking and SHS cause airway obstruction through broncho-
constriction, inflammation and airway remodeling (Flouris, et al., 2010). SHS of one hour 
duration decreased lung function as evidenced by a 20 to 25% reduction in forced 
expiratory volume in one second (FEV1)  (p = < .05) (Flouris, et al., 2009). Non-smoking 
hospitality workers (n =88) in Vancouver who were employed in bars and restaurants 
where smoking was allowed had increased odds ratios (OR) for cough (OR 3.5), phlegm 
production (OR 8.5) and wheeze (OR 3.8) (Dimich-Ward, Lawson, Hingston, & Chan-
Yeung, 2005). Workplace SHS increased the odds for cough and phlegm by 65%  in 
workers in Hong Kong who had never smoked and had no SHS at home (Ho, Lam, 
Chung, & Lam, 2007). The risk of a new-onset of asthma in a random sample of never-
smoking adults aged 18 to 60 increased by 39% with SHS exposure (Leuenberger, et al., 
1994). In a survey of 377 people with COPD only 19% had never smoked with a 
population-attributable risk of 51% for current or former smoking, after controlling for 
demographics and self-reported occupational exposure to other irritants (Trupin, et al., 
2003). 
Cigarettes contain over  600 ingredients which when burned create more than 
4000 chemicals including acetone, ammonia, benzene, butane, carbon monoxide, 
hydrogen cyanide, lead, nicotine, sulfur dioxide tar, and toluene (USDHHS, 2006). 
Tobacco smoke also contains at least 50 known carcinogens. SHS contains levels of 
endotoxins that increase inflammation that are 120 times higher in SHS than in non-
exposed air (Larsson, Szponar, & Pehrson, 2004).  
Two other less conspicuous but potentially damaging forms of tobacco smoke 
exposure are thirdhand smoke and outdoor tobacco smoke. Thirdhand smoke is the gas 
and particle residue from tobacco smoke that lingers in the air and on surfaces after the 
cigarette is extinguished (Winickoff, et al., 2009). The nicotine residual on indoor 
surfaces such as floors, walls, furniture and clothing reacts with nitric oxide to form 
tobacco-specific nitrosamines (TSNA) which are carcinogenic. These TSNAs can enter 
the body through inhalation of contaminated dust (Sleiman, et al., 2010). 
As indoor smoke-free legislation is enacted, outdoor tobacco exposure still occurs 
and can result in high levels of nicotine among non-smokers. In a study of 10 non-
smokers who spent an average of 25 days at outdoor bars and restaurants that allowed 
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smoking in Athens, Georgia, salivary cotinine increased by up to 162% from baseline 
after outdoor SHS exposure (Hall, et al., 2009). Outside nightclubs, the average level of 
particulate matter (PM2.5) was 32.2µg/m3 , close to the National Ambient Air Quality 
Standard (NAAQS) for 24 hours  (35 µg/m3) (EPA, 2009). 
Smoke-free policies in cities and countries have been shown to decrease ambient 
levels of cigarette-related chemicals. In Dublin before a smoke-free ordinance was passed 
the levels of benzene and 1,3-butadiene in two pubs averaged 4.83 µg/m3 and 4.15 µg/m3 
respectively. These levels dropped to 0.54 µg /m3 and 0.22 µg /m3 after successful 
implementation of the policy which had a  97% compliance nationwide (McNabola, 
Broderick, Johnston, & Gill, 2006). Nine hospitality venues in Georgetown, Kentucky 
had PM2.5  levels averaging 84µg/m3 before an indoor smoke-free workplace law was 
enacted which decreased to 18µg/m3 one week after the law went into effect (Lee, et al., 
2007). In nonsmokers, cotinine levels, a metabolite of nicotine, decreased by 89% from 
baseline one year after Scotland enacted smoke-free legislation in March, 2006 (Semple, 
et al., 2007). 
The decreases in environmental irritants, nicotine and fine particle air pollution 
after smoke-free laws have been enacted are associated with improvements in respiratory 
symptoms. In Lexington, Kentucky there was an overall 22% reduction of emergency 
department visits for asthma in the 32 months after passage of a smoke-free law 
prohibiting smoking in most indoor public places compared to the 40 months prior to the 
law (p <.001; confidence interval (CI) 14% to 29%) (Rayens, et al., 2008). Hair nicotine 
levels declined significantly in bar workers (t = 2.3, p = .03) in Lexington, KY and they 
also reported significant reductions in wheezing, irritated eyes and mucus production 
after passage of the smoke-free ordinance in public places (p values from .02 to .05) 
(Hahn, et al., 2006). Bar workers in Perthshire, Scotland reported a decrease in 
respiratory symptoms within one month of a smoke-free law (p < .001) (Menzies, et al., 
2006). Fifteen of the 105 bar workers had asthma. The FEV1 in the entire cohort 
increased by 8.2% after one month (CI 3.9-12.4, p < .001) and by 15.7% in those with 
asthma (CI 5.7-25.7, p = .008). 
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Tobacco policies in prisons 
There are three basic types of tobacco policies in prisons: indoor smoke-free with 
smoking allowed outdoors or in designated areas; comprehensive smoke-free policies 
which prohibit all smoking on the grounds; and tobacco-free policies in which all tobacco 
products are prohibited on the prison grounds. Tobacco-free policies include smokeless 
and spitless tobacco and may also apply to nicotine replacement products. Typically these 
policies apply to all staff, inmates, and visitors.  
Within one state system the policies may vary. The Kentucky Department of 
Corrections (KYDOC) has had a smoke-free policy for over ten years in its 13 state 
prisons. The KY General Assembly reinforced this policy with the passage of KY House 
Bill 55 in 2006 which required most state offices and common areas to be smoke-free 
including all correctional facilities except the Kentucky State Penitentiary at Eddyville 
which is the maximum security prison for male state inmates (2006). Five of the KY 
DOC prisons have also adopted a tobacco-free campus policy in which no tobacco of any 
form is allowed beyond the security gate at the front entrance. This policy applies to 
inmates, visitors, and staff and in prison vehicles. Any tobacco found on the premises is 
considered contraband similar to illicit drugs such as heroin, and the person (staff or 
inmate) in possession of tobacco products is subject to disciplinary procedures.   
Air quality studies in prisons have shown that there can be significant reductions 
in SHS following tobacco-free policies but enforcement is the critical factor in reducing 
tobacco use. In North Carolina there was a 98% decrease in SHS as measured by PM2.5  in 
a dormitory where the level was 305 µg/m3 before a tobacco-free policy and 6.5µg/m3 
after the policy was implemented (Proescholdbell, et al., 2008). However, levels of SHS 
may vary even within prisons. In three Kentucky prisons, two of which had an indoor 
smoke-free policy and one that had a tobacco-free policy, the maximum level of PM2.5 in 
three medium security dormitories was more than double that of the maximum level of 
PM2.5 in minimum security dormitories in the same prisons (McGuire & Connell, 2010).                           
Research on the effects of tobacco-free policies on the health of inmates has not 
been published. Given that there have been improvements in lung function and 
respiratory symptoms after passage of smoke-free laws in communities and countries it is 
anticipated that a tobacco-free policy in prisons which prohibits all tobacco products on 
 
31 
 
the grounds would result in improvements in the respiratory health of inmates. The 
purpose of this study was to evaluate the effect of a tobacco-free prison policy compared 
to an indoor smoke-free policy on the respiratory health of inmates who have asthma 
and/or COPD. It was hypothesized that due to expected reductions in the rate of current 
smoking and subsequent SHS in tobacco-free prisons, inmates in these prisons would use 
fewer medications for asthma and/or COPD compared to inmates with asthma and/or 
COPD in prisons that were not completely tobacco-free.  
Methods 
This study was a multivariate time series analysis to evaluate the effect of 
tobacco-free policies in two state prisons on the respiratory health of inmates with asthma 
and/or COPD compared to inmates with asthma/COPD who were incarcerated at two 
state prisons designated as smoke-free (smoke-free indoors, with smoking allowed 
outdoors). Medications for asthma and/or COPD including oral medications and inhalers 
were used as proxy markers for respiratory health. The study period was at least 12 
months prior to and 18 months after the implementation dates of the respective policy. 
Institutional Review Board approval was obtained through the University of Kentucky 
and in addition, was approved by the Commissioner for the Kentucky Department of 
Corrections. 
Study Setting 
Four Kentucky state prisons were chosen for this study, two of which adopted 
tobacco-free campus policies and two that had indoor smoke-free policies. Blackburn 
Correctional Complex (BCC) and Kentucky Correctional Institution for Women (KCIW) 
implemented tobacco-free policies between July and September, 2007. The tobacco-free 
policy applies to all tobacco products and to all staff, inmates and visitors. The two 
prisons with smoke-free policies (smoke-free indoors, with smoking allowed outdoors) 
were Eastern Kentucky Correctional Complex (EKCC) and Little Sandy Correctional 
Complex (LSCC). Table 3.1 describes the population and the security level of inmates at 
each prison.  
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The study prisons could not be matched by security status or gender because 
security status varied between the two policy study groups and there is only one female 
prison managed by the KYDOC. BCC is the largest minimum security prison in the KY 
DOC with the other minimum security prisons having a population of 300 inmates or 
fewer; matching a minimum security prison of the same size was not possible. Matching 
prisons based on gender was also not possible since the only other female prison in 
Kentucky is managed by a private company and comparable data were not available. The 
majority of the inmates in the two smoke-free prisons (EKCC and LSCC) were in 
medium security and they live and work “behind the fence” with no access to the free 
world (see Table 3.1). Inmates living in a minimum security prison such as in BCC 
usually have fewer restrictions and often work on community needs projects such as 
road-cleaning crews, and consequently, have more access to the outside world and more 
opportunity to use tobacco when off the prison campus. 
Diamond Pharmaceutical is the vendor for the 13 KY DOC prisons. Prescriptions 
are electronically ordered by the primary care providers (PCP) at the prisons via the 
electronic health record (EHR). Once the order is approved by a Diamond pharmacist, 
maintenance medications are distributed in 30-day blister packs. Some inmates receive 
medication while being directly observed by medical staff personnel and a corrections 
officer (Direct Observation Therapy or DOT) while other inmates are permitted to 
receive a thirty-day supply of medications for self-administration (Self-administered 
Medications or SAMs). The SAMs inmate population functions similarly to most non-
incarcerated patients: they fill or refill medication every month and are responsible for 
taking their medication without supervision. To refill medications, inmates on SAMs 
must come to “pill call” which is at a designated time in each prison to request a refill of 
their medication and then return 2-3 days later to pick up the next month’s supply of 
medication (similar to the non-incarcerated population). Inmates who get their 
medication by the DOT method must present to “pill call” daily to take their medication 
directly from medical staff who document acceptance or refusal to take the medication. 
Refills for DOT medications are requested by prison staff when there is one week’s 
supply of pills left in the blister pack. Very few respiratory medications are administered 
using the DOT method since most are inhalers and many are used as needed.   
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Study Sample 
The unit of analysis in the study was the number and types of medications for 
asthma and/or COPD (N = 6,374) that were sent by Diamond Pharmaceutical to the 
prison each month. These medications were dispensed to 1,109 inmates over the course 
of the study (see Table 3.4). However, since these data were obtained from the pharmacy 
vendor only demographic data including inmate number, date of birth, gender and prison 
were available. Tracking individual inmates’ movement between and among prisons was 
not feasible which precluded a count of medications per treated patient per month since it 
was unknown on a monthly basis if the inmate continued to be housed in each prison. 
Inmates typically move multiple times each year between prisons and also shorter trips to 
court appearances, medical consultations or hospitalizations. Typically inmates move 
from one prison to another an average of 1.1 times per year and have been reported to 
move up to seven times in one year (Unpublished, Connell, 2010). With over 1,100 
inmates over three years, tracking these data longitudinally was not feasible.  
Measures 
Medications were in the form of either inhalers or pills. There are two basic types 
of inhalers for asthma/COPC: rescue inhalers which are used as needed for immediate, 
short-term bronchodilation and long-term inhalers which are taken daily to reduce airway 
inflammation and chronic bronchoconstriction. Albuterol, ipratropium bromide and 
Combivent (albuterol and ipratropium) metered dose inhalers (MDI) were coded as short-
acting. Q-var, Advair, Azmacort, and Spiriva were coded as long-acting inhalers. All oral 
medications were coded as oral (see Table 3.2).  
Data from Diamond included the inmate number, birth date, medication, quantity 
and date the medication was sent to the prison. This date was not necessarily when the 
inmate picked it up from “pill call” but it is an indicator that the inmate or the DOC staff 
requested a refill on the medication. The numbers of prescriptions ordered by the PCP for 
the medication for these drugs were not analyzed because that would not reflect actual 
use of the medication by the inmate.  
The tobacco-free policy was termed “intervention” and was entered as a binary 
variable of ‘0’ for smoke-free (indoors) at EKCC and LSCC for each month in the entire 
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study period and 15 months at BCC and 12 months at KCIW prior to the tobacco-free 
policy. The policy variable was coded as ‘1’ for tobacco-free for the 18 months after 
implementation of the tobacco-free policy at BCC and KCIW. 
In order to calculate the medication rates as metered dose inhalers (MDI) per 
1000 inmates, monthly counts of all the inmates in each prison were obtained from the 
Kentucky Offender Management System (KOMS), the database that tracks all inmate 
locations and movement. This allowed for equal comparisons among facilities of 
different sizes. Age was entered as the age when the refill was sent. Smoking history of 
the sample was not available since the data were derived from the pharmaceutical vendor.  
Study Period 
The full 36-month period was not available for all four study prisons because 
Diamond began the contract with the KYDOC on July 1, 2006 (see Table 3.3). For the 
two tobacco-free prisons (BCC and KCIW), data were available for 18 months after 
policy implementation, but the pre-policy periods varied.  Data were available for 15 
months pre-policy at BCC and 12 months pre-policy at KCIW so that the total study 
period was 33 months at BCC and 30 months at KCIW. For the two prisons with a 
smoke-free policy (smoke-free indoors, outdoor smoking allowed), data were available 
for 30 months at EKCC and 18 months at LSCC. The data from Diamond were not 
available for LSCC prior to July 2007 because the facility had been privately managed by 
a different pharmacy vendor.   
Statistical Analysis 
Descriptive statistics were used to summarize the sample of inmates who were 
taking the asthma/COPD medications including demographic data of gender and age 
(range and means) in each prison. Race/ethnicity data were not available in the Diamond 
database.  
Poisson regression with a fixed effect for the facility was used in a generalized 
linear mixed model. The Poisson regression was the most appropriate technique given the 
small number of inhalers each month since it assumes a non-parametric distribution and 
determines the rate of medication use from the logarithm of the offset variable. The 
monthly inmate count in each prison from KOMS data was entered as the offset variable. 
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Facility was included in the model as a fixed effect and an intervention indicator variable 
was entered as a binary categorical variable for the smoke-free or tobacco-free policy. 
”Month time” was entered as the number of the month in which a particular data point 
was collected during the course of the study, starting with July 2006 as ‘1’ until the end 
of data collection which was from 1 to 30 for KCIW and EKCC, 1 to 33 for BCC, and 
from 13 to 30 for LSCC since the data collection started in July 2007. Seasonality was 
found not to be significant when a 12-month lag autoregressive term was entered in an 
autoregressive integrated moving-average (ARIMA) model. Two-way interaction terms 
were included: month time*facility, intervention*month time, intervention*facility, and a 
three-way interaction of intervention*month time*facility. 
Results 
From July 2006 through December 2009, there were a total of 6,374 inhalers and 
oral medications for asthma and/or COPD dispensed to a total of 1,109 inmates (see 
Table 3.4). There were differences in the number of inmates among the prisons over the 
three-year study period (F = 25.22, df = 3, p < .001). KCIW (all female) had almost twice 
the number of inmates than the male facilities which is likely due to shorter sentencing 
times and higher turnover of inmates. BCC also had a higher proportion of treated 
patients for its size suggesting high turnover rates. Among the four different prisons, the 
mean age at the time the inmate refilled the medication was significantly different with 
KCIW having the lowest mean age (39.2 years), and BCC having the highest ( 45.2 
years) (F = .15.56, df = 3, p = <.001). However, since BCC and KCIW are the tobacco-
free prisons these were grouped together to determine if there was a difference between 
the two groups of tobacco-free and smoke-free prisons. When the groups were combined, 
the mean age of the inmates was not significantly different (F = .78, df = 1, p = .375).  
Short-acting inhalers were the most commonly used (72.0%); long-acting inhalers 
second most common (20.2%); and oral medications third (7.8%). There were distinct 
differences in the proportion of each type of medication by facility with significantly 
higher rates of use of inhalers at the tobacco-free prisons (BCC and KCIW) than the 
smoke-free (indoors) prisons (EKCC and LSCC). There were significant differences 
between the two smoke-free and two tobacco-free prisons for short-acting inhalers (F = 
 
36 
 
401.94, df = 1, p < .0001), long-acting inhalers (F = 58.84, df = 1, p < .0001), but not for 
oral medications used for asthma and/or COPD (F = 1.03, df = 1, p = .31). Prescribing 
differences by the provider were noted particularly with the use of non-formulary drugs 
(Advair and Spiriva) at the tobacco-free prisons (BCC and KCIW) with none of those 
two at the smoke-free prisons (EKCC and LSCC). Of the oral medications, theophylline 
was prescribed more at EKCC than at the other three prisons. Of 259 oral medication 
refills, 217 (83.8%) were for theophylline compared to an average of 61.3 dispensed at 
the other three prisons over the study period.  
Short-acting Inhaler Use after Tobacco-Free Policy Implementation 
The final Poisson regression model for short-acting inhalers showed a significant 
intervention effect (F= 7.95, df = 101, p = .006). The three-way interaction term of 
intervention by month time by facility was not significant (p = .18) and was removed. 
Significant two-way interaction effects were observed between intervention*month time 
(F =9.90, df = 99, p = .002) and between month time*facility name (F= 7.95, df = 99, p < 
.0001). Since the log of the monthly inmate count from KOMS was used as an offset 
variable, the model for short-acting inhalers is:  
y = eβ0 + eβ1intervention + e β2facility + e β3month time e β4 month time*facility + 
eβ5intervention*month time  
A graph of the output from the regression model for short-acting inhalers is 
shown in Figure 3.1. At the tobacco-free prisons (BCC and KCIW), the rate of short-
acting inhalers was decreasing prior to implementation of the tobacco-free policy 
(marked by the dotted vertical lines). The inhaler use dropped in the month after the 
policy was implemented but increased gradually back to the level of use prior to policy 
implementation within 12 months at BCC and 14 months at KCIW.  Inhaler use gradually 
increased at EKCC and decreased at LSCC (smoke-free indoors).  
Long-acting Inhaler use after Tobacco-Free Policy Implementation 
The model for long-acting inhalers was significant with a three-way interaction 
effect of intervention by month time by facility (F = 20.59, df = 99, p < .0001). Figure 3.2 
displays the results of the regression model for long-acting inhalers with the intervention 
effect. At the prisons that became tobacco-free (BCC and KCIW) there were opposite 
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effects before and after the tobacco-free policy was implemented. Prior to the 
implementation date at BCC, the use of long-acting inhalers was gradually decreasing but 
was increasing at KCIW.  However, after the policy was implemented, the rate increased 
monthly at BCC and decreased at KCIW. Rates of use returned to the rate prior to the 
policy date within 7 months at BCC. The rate at KCIW did not return to baseline by the 
end of the study period. The two prisons with indoor smoke-free policies (EKCC and 
LSCC) also had opposite trends in long-acting inhaler use with gradual increases at 
EKCC and decreased use at LSCC.  
Oral Medication Use after Tobacco-Free Policy Implementation  
Oral medications use was not significantly affected by the tobacco-free policy 
implementation (F=0.00, df = 102, p < .99). There was a two-way interaction between 
month time and facility (F=6.86, df = 102, p = .0003) in which the rate of use of the 
medications changed over time with the rate of use of oral medications decreasing over 
the study period at EKCC and LSCC (smoke-free indoors) and increasing at BCC and 
KCIW (tobacco-free prisons) (see Figure 3.3). 
Discussion 
This study was designed to determine the effect of tobacco-free prison policy on 
the respiratory health of inmates with asthma and/or COPD. Respiratory health was 
measured by the proxy use of short- and long-acting inhalers and oral medications. The 
hypothesis that tobacco-free policies would result in improvements in respiratory health 
as indicated by decreased use of medications for asthma and/or COPD was partially 
supported. There was an immediate effect of the tobacco-free policy on the use of short-
term inhalers such as albuterol and ipratropium within a month after the policy was 
implemented. However, the rate of use gradually increased to the level prior to the policy 
implementation within 12 to 15 months at the tobacco-free prisons. The rate of refills of 
long-acting inhalers had opposite trends before and after implementation of the tobacco-
free policy. There was no effect of the policy intervention on the use of oral medications 
but there seemed to be a prescribing effect by the primary care providers with differences 
in the use of certain medications in the four prisons. 
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The results pose more questions than answers about the inconsistent effect of the 
tobacco-free policy given that improvements in respiratory health have been seen in the 
non-incarcerated population following smoke-free laws in public places and workplaces. 
The reasons for this are that inmates may continue to smoke after tobacco-free policies 
have been implemented or that the security status of the prison allowed for easier access 
to tobacco following policy implementation. Inmates tend to continue smoking after 
prisons adopt comprehensive smoke-free policies or tobacco-free policies, with 76% of 
male inmates reporting smoking one month after a comprehensive smoke-free policy 
(indoors and out) was implemented (Cropsey & Kristeller, 2005b). Inmates in a prison 
that had adopted a complete tobacco-free prison policy reported that 42% continued to 
smoke compared to 64% in a prison that had an indoor-only tobacco-free restriction 
(Proescholdbell, et al., 2008).  
The security status of the prisons may affect the use of tobacco and the 
enforcement of the policy. Access to tobacco is greatest in minimum security status 
prisons according to inmates and officers (Lankenau, 2001). There are fewer restraints 
such as barbed wire fences, guard towers and many are more farm-like which gives 
inmates the opportunity to obtain tobacco from outside sources or while they are on 
work-release in the community. The two tobacco-free prisons in this study were BCC 
which is a 500 acre minimum security prison with no fences and KCIW which houses 
medium and minimum security inmates. The two tobacco-free prisons (BCC and KCIW) 
also differ from the two smoke-free (EKCC and LSCC) prisons by having a more rapid 
turnover. BCC is the facility that inmates move to as a step-down from higher security 
levels in the year prior to discharge so most are housed there for less than one year. 
Women tend to have shorter sentences than men. The influx of new inmates may affect 
the medication refill rate as inmates move to tobacco-free prisons from other prisons and, 
as a matter of course, get their chronic medications refilled. Inmates who move to these 
prisons also may have been smoking and continue to have respiratory symptoms after 
entry to a tobacco-free prison. 
Enforcement of the smoke-free and tobacco-free policies may have affected the 
findings of this study. Implementation effectiveness can affect the current smoking rate 
and SHS exposure (Lee, et al., 2009) which could affect respiratory health indicators. 
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Enforcement may have been stronger immediately after the policy went into effect and 
waned over time given that the use of short-term inhalers decreased significantly in the 
few months afterwards and within a year or so was back to the previous level. 
Approximately two years after BCC and KCIW became tobacco-free prisons, a study 
measuring PM2.5  levels in two dormitories in each of the four prisons used in this study 
was conducted (Unpublished, McGuire & Connell, 2010). At BCC (tobacco-free) which 
is all minimum security, the maximum PM2.5  was 11.2 µg/m3 in one dormitory and 30.4 
µg/m3 in a second. At KCIW (tobacco-free) the maximum level in two dormitories was 
4.1 µg/m3 and 15.0 µg/m3. At the two smoke-free prisons (EKCC and LSCC), the highest 
level in a medium security dormitory at each prison was 37.5 and 37.1 µg/m3 but was 
16.5 and 17.4 µg/m3 in a minimum security dormitory at the same prisons indicating that 
there may be variations in enforcement of the policy within prisons which may affect the 
respiratory health indicators measured in this study.  
The study results indicate that primary care providers such as the physicians and 
nurse practitioners need to continue to counsel their patients on tobacco cessation 
regardless of the tobacco policy of the prison. In prisons with indoor smoke-free policies, 
providers should also encourage current smoking inmates not to smoke indoors to reduce 
the exposure to non-smoking inmates. In prisons with tobacco-free policies, providers 
should not assume that inmates are not smoking once the policy is implemented.  
The main policy implication is that the success of a tobacco-free policy in 
reducing the use of tobacco depends on the consistent enforcement of the policy in 
dormitories and outside. Most states report that tobacco becomes the most common form 
of contraband after a tobacco-free policy is implemented which to many administrators is 
better than smuggling heroin (NCCHC, 2004). This presents challenges to correctional 
officers who have many other forms of contraband to deal with including cell phones, 
knives (shivs), and illicit drugs. A replication of this study in a tobacco-free medium 
security prison in which tobacco is harder to smuggle would help to determine the effect 
of the looser structure of a minimum security prison on the effect of the policy.  
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Limitations 
The primary limitation in this study was the lack of longitudinal inmate 
movement data which are available in the Kentucky Offender Management System 
(KOMS). Longitudinal person-level data that tracks the location of the inmates each 
month would allow for calculation of the rate of medication use per inmate with asthma 
and/or COPD, as opposed to the rate of medication use per capita in each prison. The 
inmate movement is the critical piece of missing data since it was not possible to 
determine if an inmate did not refill a medication, whether the inmate had better 
asthma/COPD control, or whether he or she had been moved to another prison or was 
discharged. The rate of turnover in the prisons was not available to control for the influx 
and outflow of inmates. These data may be available from the KY DOC but is more 
likely to be aggregated quarterly or yearly rather than daily. Also, in this study, since the 
data were obtained from the pharmaceutical vendor, demographics such as race/ethnicity, 
co-morbidities, or other medication use was not entered into the model. Smoking status 
of the inmates was also not known.    
A second limitation is that enforcement was not assessed and air quality was not 
measured before and after the tobacco-free policy to document compliance with the 
policy. The study using PM2.5  in the four prisons was done two years after the tobacco-
free policy was implemented, and pre-policy air quality data are unknown. The best way 
to gauge enforcement would be to measure PM2.5  before and at varying time periods after 
to assess policy compliance over time.  
The third main limitation was that the tobacco-free policy was implemented in the 
two prisons with more rapid turnover rates and many if not all, minimum security 
inmates (BCC and KCIW) than the smoke-free prisons which were 95% medium security 
(EKCC and LSCC). Kentucky State Reformatory (KSR) is a tobacco-free, medium 
security prison and the medical facility for the state and has a more stable population with 
fewer turnovers due to housing inmates who are more ill. However, medication data were 
not available prior to the prison becoming tobacco-free because Diamond 
pharmaceuticals did not have the contract with the KY DOC prior to the tobacco-free 
policy implementation at KSR.  
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Future research is suggested using a prospective study of inmates with a diagnosis 
of asthma and/or COPD in Kentucky prisons with varying levels of tobacco-free policy. 
These inmates could be assessed for biomarkers of SHS exposure, demographic data and 
FEV1 measurements, salivary cotinine levels, personal smoking history and movements 
between prisons to control for person-level data and the influx of inmates into and out of 
prisons with different tobacco policies. EHR records of provider prescriptions could be 
documented as a control variable. These data could be entered in a generalized linear 
regression model to determine the effect of the tobacco policy on biological markers of 
smoke exposure and lung function.  
The optimal time to conduct a policy analysis study on health outcomes is when 
an entire state Department of Corrections adopts a tobacco-free policy such as in 2010 
when Nevada, Virginia, North Carolina and Georgia become tobacco-free in all prisons 
simultaneously. In this setting all inmates receive the same intervention (i.e., tobacco-free 
policy) so that the only inmate movement data needed would be the dates of admission 
and discharge into and out of the prison system. Month by month tracking would not be 
necessary since every prison would have the same policy. 
Conclusion 
The hypothesis that there would be a reduction in inhaler and oral medication use 
after the implementation of a tobacco-free policy in Kentucky state prisons was partially 
supported. There was an immediate reduction in use of short-term inhalers following the 
tobacco-free date in both of the intervention prisons but the rate gradually increased to 
baseline within 12 to 15 months. The turnover of inmates in the two prisons with a 
tobacco-free policy is postulated as the most likely reason for this gradual increase in 
short-term inhaler use but movement data were not available from the pharmaceutical 
vendor. The logistical issues of tracking thousands of inmates over time intervals from 
one movement to the other precludes the use of KOMS data unless it were for a smaller 
sample.  
Given the improvements in respiratory health indicators in the non-incarcerated 
population secondary to smoke-free laws in public places and workplaces and the short-
term benefit of the tobacco-free policy in this study, comprehensive tobacco-free prison 
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policies may improve the respiratory health of inmates. Enforcement of tobacco-free 
policies is the key to implementation effectiveness especially in minimum security 
prisons where tobacco may be more readily accessible.  
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Table 3.1 Characteristics of accessible population of prisons by policy status 
Prison Average  Inmate 
Population 
Gender Security Status Policy Status 
Blackburn 
Correctional 
Complex (BCC) 
594 Male Minimum Tobacco-free 
prison policy 
Sept 17, 2007 
Kentucky 
Correctional 
Institution for 
Women (KCIW) 
682 Female Minimum/Medium/ 
Maximum/Death Row 
Tobacco-free, 
prison policy 
July 1, 2007 
Eastern Kentucky 
Correctional 
Complex (EKCC) 
1689 Male Medium (1639 
inmates) 
Minimum (50 inmates)  
Smoke-free 
inside only 
 
Little Sandy 
Correctional 
Complex (LSCC) 
992 Male Medium (892 inmates) 
Minimum(100 
inmates) 
Smoke-free 
inside only 
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Table 3.2 Study variables 
Variable Name Coding Type of Data 
Facility Name Name of prison (BCC, KCIW, EKCC, LSCC) Nominal 
Tobacco policy ‘0’ for smoke-free (indoors)   
‘1’ for tobacco-free  
Nominal   
Month Time Number of months during the study period starting 
with July 2006 as ‘1’ to ‘33’ for BCC in March 2009  
Continuous 
Age at Fill Age calculated as the age at the time of refill Continuous 
Inmate Count Monthly inmate count in each prison from KOMS Continuous  
Short Acting 
Inhaler Use 
Short-acting inhalers (Albuterol, Ipratropium 
bromide) 
Nominal 
Long Acting 
Inhaler Use 
Long-acting inhalers (Q-var, Advair, Azmacort, 
Spiriva) 
Nominal 
Oral Medication 
Use 
Oral (Theophylline, Terbutaline, Singulair, 
Accolate) 
Nominal 
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Table 3.3 Study period dates in each prison 
Prison Study start date Tobacco-free 
date 
Study end 
date 
Number of 
months in 
study 
Blackburn Correctional 
Complex (BCC) 
July 1, 2006 Sept 17, 2007 March 31, 
2009 
33 
Kentucky Correctional 
Institution for Women 
(KCIW) 
July 1, 2006 July 1, 2007 December 
31, 2009 
30 
Eastern Kentucky 
Correctional Complex 
(EKCC) 
July 1, 2006 NA December 
31, 2009 
30 
Little Sandy 
Correctional Complex 
(LSCC) 
July 1, 2007 NA December 
31, 2009 
13 
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 Table 3.4 Demographic data by inmate and medications 
  Tobacco-free 
prisons 
Smoke-free (indoor) 
prisons 
Demographic data Total BCC KCIW EKCC LSCC 
Total population  594 682 1689 992 
Total sample of inmates 1109 281 461 240 127 
Age Range 19-75 20-75 19-64 20-75 19-75 
Age Mean 41.7 45.2 39.2 40.7 41.7 
Gender M/F Male Female Male Male 
Total medications 6374 1898 1622 1905 949 
Short-acting inhalers 4587 1437 1220 1313 617 
Long-acting inhalers 1289 380 305 333 271 
Oral medications 498 81 97 259 61 
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Figure 3.1 Short-acting inhalers (MDIs per 1000 inmates per month) 
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Figure 3.2 Long-acting inhalers (MDIs per 1000 inmates per month) 
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Figure 3.3 Oral medication use (Theophylline, Terbutaline, Singulair, Accolate) 
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CHAPTER 4: TOBACCO-FREE PRISON POLICY AND ACUTE MYOCARDIAL 
INFARCTION AMONG INMATES 
Synopsis 
Purpose: The purpose of this study was to determine the effect of a tobacco-free 
policy on the hazard of acute myocardial infarctions (AMI) in inmates compared to 
inmates in prisons that had indoor smoke-free policies. Smoke-free in the KY DOC 
means that there is no smoking indoors but outdoor smoking is allowed. Tobacco-free 
means that no tobacco of any kind is allowed on the grounds of the prison. 
Hypothesis: It was hypothesized that there would be a lower hazard for having an 
AMI in the tobacco-free prisons than the smoke-free (indoors) prisons, where 70% of the 
inmates could continue to smoke outside. 
Method: The study design was a retrospective survival analysis on the time to first 
AMI using censored intervals with tobacco policy status (tobacco-free or smoke-free) of 
the prison as the primary predictor variable.  
Sample: A list of all inmates (N = 87) who had a hospital discharge diagnosis of 
AMI between January 1, 2005 through December 31, 2009 in six state prisons in 
Kentucky was obtained from the health care management company for the KY DOC. 
Results: The hazard ratio for an AMI for the time inmates were housed in a prison 
with an indoor smoke-free policy was 2.87 compared to the time spent in a tobacco-free 
environment after controlling for facility, past smoking status, co-morbidities, race and 
age.  
Conclusions: There is an increased hazard for having an AMI while living in a 
prison with an indoor smoke-free policy where smoking is allowed outdoors which may 
be a result of current smoking by approximately 70% of inmates and subsequent outdoor 
secondhand smoke (SHS) exposure for non-smoking inmates. There is a clear policy 
implication for prisons to adopt tobacco-free policies instead of indoor smoke-free 
policies to improve the health of inmates. 
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TOBACCO-FREE PRISON POLICY AND ACUTE MYOCARDIAL INFARCTIONS 
AMONG INMATES 
Introduction 
Cigarette smoking is the leading cause of death in the United States, causing 21% 
of all deaths. Secondhand smoke (SHS) is estimated to cause between 57,800 to 97,700 
AMIs annually and between 33,500 and 56,900 deaths from coronary heart disease per 
year (Lightwood, et al., 2009; Peto, et al., 2006). SHS has been estimated to cause 80% to 
90% as much damage as smoking (Barnoya & Glantz, 2005). Secondhand smoke is 
defined by the American Cancer Society (ACS) as a combination of sidestream smoke 
which is the smoke from the end of a lit cigarette, cigar or pipe, and mainstream smoke 
which is the smoke exhaled by the smoker (ACS, 2010). The 2006 Surgeon General’s 
report on “The health consequences of involuntary exposure to tobacco smoke” reviewed 
the scientific evidence to date and concluded that there is no risk-free level of exposure to 
SHS and that separate smoking areas within a building cannot eliminate SHS (USDHHS, 
2006). 
Outdoor SHS also produces measurable levels of nicotine in non-smokers. In a 
study of 10 non-smokers who spent an average of 25 days at outdoor bars and restaurants 
that allowed smoking in Athens, Georgia, salivary cotinine, a nicotine metabolite, 
increased by up to 162% from baseline after outdoor SHS exposure (Hall, et al., 2009). 
Outside nightclubs in Athens, Greece, the average outdoor level of fine particulate matter 
(PM2.5) from the burning end of a cigarette was 32.2µg/m3, exceeding the standard 
maximum level set by the Environmental Protection Agency (EPA) of 15 µg/m3 for 
annual exposure and is close to the 24-hour standard of 35 µg/m3 (EPA, 2009). 
The overall relative risk for coronary heart disease for people who smoke is 1.78 
and 1.31 for people exposed to SHS (Barnoya & Glantz, 2005). However there is a dose-
dependent effect from increasing cigarette exposure as reported in a large international 
study, the INTERHEART study which was designed to examine cardiovascular risk 
factors for acute myocardial infarction (AMI) including the effects of smoking and 
secondhand smoke on the risk for AMI (Teo, et al., 2006). The study enrolled 15,152 
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cases of first AMI matched by age and sex with 14,820 controls in 52 countries. The odds 
ratio (OR) for AMI increased by 1.056 for every additional cigarette smoked per day so 
that a person who smoked 40 cigarettes per day had an OR of 9.16. There was an 
increased risk of AMI with increasing hours of SHS. The OR for having an AMI was 
1.24 with 1 to 7 hours per week of SHS which increased to 1.62 for people living with a 
spouse who smoked or who were exposed over 21 hours per week. 
Smoke-free legislation in communities, states, and nations, has resulted in 
reductions in the incidence of acute myocardial infarctions (AMI) as concluded by the 
Institute of Medicine (IOM) (IOM, 2009). The 2009 IOM report summarized the data on 
the incidence of AMI following smoke-free policies in 11 national and international 
locales and found that there is sufficient evidence to infer a causal relationship between 
SHS and coronary heart disease and that smoke-free policies reduce the risk for AMI.  
The first report on the incidence of AMI following enactment of a smoke-free 
ordinance was from Helena, Montana in 2002. Over the next six months there was a 40% 
reduction in AMIs (Sargent, et al., 2004). A time-series study using the 18 month period 
before and after an ordinance was implemented in Pueblo, Colorado found a 27 percent 
reduction in AMI hospitalizations in the City of Pueblo and no decrease in the adjacent 
county where public smoking was allowed (Bartecchi, et al., 2006). New York State 
passed a comprehensive smoke-free policy in 2003. In the following year there were 
3813 fewer hospital admissions (8% reduction) for AMI than expected after adjusting for 
seasonal and secular trends (Juster, et al., 2007).  
Reductions in AMI have also been reported at the national level after countries 
have enacted smoke-free policies in indoor public places. The hospitalization rate for 
AMIs in a region of Italy decreased by 11% among people less than age 60 after a 
prohibition on indoor smoking in public places in 2005 (Barone-Adesi, et al., 2006). In 
the 10 months after smoking was prohibited in public places in Scotland, there was a 17% 
reduction in the incidence of hospitalizations for AMI compared to a 4% reduction in 
England which did not have a smoke-free policy (Pell, et al., 2008). Two meta-analyses 
on studies on AMI incidence following smoke-free policies found that there was a 17% 
reduction in the rate of hospitalizations for AMI worldwide where smoke-free policies 
were enacted (Lightwood & Glantz, 2009; Meyers, et al., 2009). The research is clear that 
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smoke-free legislation reduces AMIs but there is no research on the effects of 
comprehensive smoke-free (indoors and out) or tobacco-free prison policies on AMIs 
among inmate populations. 
Tobacco use and policy in United States prisons 
In the United States, prison inmates as a sub-population have three times higher 
rates of current cigarette smoking than the non-incarcerated population, with current 
smoker rates reported from 42% to 91% with an average of 70 to 74% (Cropsey, et al., 
2006; Durrah, 2005). Tobacco related disease is common in inmates. The leading cause 
of death in inmates is cardiovascular disease, as it is in the general population, accounting 
for 27% of the deaths in state prisons between 2001 and 2004 (Mumola, 2007).   
The cost of health care from tobacco-related diseases is a primary reason that 
correctional departments have adopted increasingly restrictive tobacco policies. The 
Kentucky Department of Corrections (KY DOC) reported that the highest medical cost 
by category was for the treatment of diseases of the circulatory system: $3.4 million in 
the 10 months from July 1, 2008 to April 30, 2009 (Upton & Spaulding, 2009). The 
United States Supreme Court determined that deliberate indifference to inmates’ serious 
medical needs constituted an Eighth Amendment violation ("Estelle v. Gamble," 1976), 
so that inmates must receive health care which cost $3.3 billion in the 50 state prison 
systems in 2001, representing 12% of the total operating cost (Stephan, 2004).  
Smoke-free and tobacco-free policies are becoming more prevalent in correctional 
systems. By 2004 the majority of state correctional departments and the Federal Bureau 
of Prisons had adopted indoor smoke-free policies which allow outdoor smoking only or 
limited indoor smoking in designated areas (Zoroya, 2004). Due to the health effects of 
cigarette smoking and SHS on health and the cost of providing health care to inmates, in 
the past five years more State Departments of Corrections have adopted tobacco-free 
policies prohibiting all tobacco products on the prison campus for staff, visitors, or 
inmates. With a tobacco-free policy, tobacco is considered contraband in the same 
manner as illicit drugs, weapons or cell phones, and may carry a misdemeanor charge in 
some states and a felony charge in others such as New York and Texas (Byrne, 2006; 
Wilcox, 2007a). Tobacco, however, continues to make its way into prisons and a survey 
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by the National Correctional Commission on Health Care (NCCHC) (NCCHC, 2004) 
reported that, following a complete tobacco-free policy, tobacco usually overtakes heroin 
as the primary smuggled drug. 
Air quality studies in prisons have shown that there can be significant reductions 
in SHS following tobacco-free policies but enforcement of the policy is a critical factor in 
reducing tobacco use. In North Carolina there was a 98% decrease in SHS as measured 
by PM2.5  in a dormitory where the level was 305 µg/m3 before a tobacco-free policy and 
6.5µg/m3 after the policy was implemented (Proescholdbell, et al., 2008). However, 
enforcement of the policy may vary even within prisons. In three Kentucky prisons in 
which indoor smoking was prohibited, the highest level of PM2.5 in three medium security 
dormitories was more than double that of minimum security dormitories in the same 
prisons (McGuire & Connell, 2010). 
Health outcome studies on the effects of smoke-free or tobacco-free prison 
policies have not been reported in the literature. The purpose of this study was to 
determine the effect of a comprehensive tobacco-free policy on the hazard ratio for AMI 
in prisons with smoke-free (indoors) policies compared to prisons that had tobacco-free 
policies. Tobacco-free in the KY DOC means that no tobacco of any kind is allowed on 
the grounds of the prison. Smoke-free in the KY DOC indicates that there is no smoking 
indoors but outdoor smoking is allowed. It was hypothesized that there would be a lower 
hazard for having an AMI in the tobacco-free prisons than the smoke-free (indoors) 
prisons. Approval was obtained from the University of Kentucky Institutional Review 
Board and the Commissioner for the KY DOC.  
Methods 
The study design was a retrospective survival analysis on the time to first AMI 
using censored intervals with tobacco policy status (tobacco-free or smoke-free) of the 
prison as the primary predictor variable. Data were collected from three sources: 
CorrectCare, the KY DOC and the electronic health record (EHR). CorrectCare provided 
a list of all inmates from the six study prison sites who had a hospitalization with a 
discharge diagnosis of AMI from the time when CorrectCare commenced its contract 
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with the KY DOC starting on January 1, 2005 through December 31, 2009. Inmates who 
did not have an AMI during this 5-year period were not included in the study sample.  
Setting 
In 2003 the KY DOC formed a public/private partnership called the Kentucky 
Corrections Health Services Network (KCHSN) in order to manage the health care of 
inmates in the state prisons and contain costs while at the same time improving quality of 
care. The three KCHSN partners are the KY DOC, the University of Kentucky, and 
CorrectCare Integrated Health, Inc, a for-profit health management company. KCHSN 
implemented a comprehensive electronic health record (EHR) that allows access to the 
medical status, history, and medication record of each inmate. Secondary care data refers 
to any health care that was received by the inmate while away from the prison and is 
tracked by CorrectCare. This includes the cost and related data for hospitalizations and 
specialty consults.  
There are 16 State prisons in Kentucky, three of which are privately managed. 
The overarching policy for the KY DOC is an indoor smoke-free policy in which indoor 
smoking is prohibited and outdoor smoking is allowed. Of the 13 state-managed prisons, 
four have adopted a tobacco-free policy in which no staff or inmate may have tobacco of 
any type on the prison campus. There is also a fifth tobacco-free prison in Kentucky 
which housed female inmates but it is one of the privately managed prisons and has a 
separate medical company managing the health care of the inmates. 
Six Kentucky prisons were chosen as study sites, three of which had tobacco-free 
policies and three that had smoke-free (indoors) policies. Kentucky Correctional 
Institution for Women (KCIW), Blackburn Correctional Complex (BCC) and Kentucky 
State Reformatory (KSR) implemented tobacco-free policies between 2006 and 2007 (see 
Table 4.1). The two other tobacco-free prisons in Kentucky were not appropriate for the 
study due to one being the assessment center for the KY DOC where inmates stayed for 
less than a month on average and the other being a privately managed prison with a 
different health care management company. The three tobacco-free prisons used in the 
study were fairly unique within the state system, preventing matching prisons by gender 
or security status. KCIW is the only female prison that is managed by the KY DOC. BCC 
is the only minimum security prison which houses more than 300 inmates so there was 
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not a match of equivalent size by security status. KSR is the largest prison in the state and 
is comparable in size and security status to EKCC, since both are medium security 
prisons with over 1600 inmates. KSR is unique in that it houses inmates who have more 
complex medical needs and includes a 58 bed nursing care facility. Three prisons with 
indoor smoke-free policies (outdoor smoking allowed) were chosen randomly from the 
remaining KY DOC prisons since matching was not possible (see Table 4.1). These three 
were Eastern Kentucky Correctional Complex (EKCC), Little Sandy Correctional 
Complex (LSCC) and Luther Luckett Correctional Complex (LLCC). Table 4.1 shows 
the population and smoking status of each prison. Each of the medium security prisons 
houses a few minimum security inmates who live “outside the fence” and do maintenance 
work on the property.  
To provide information on where the inmates had been housed for at least six 
years prior to their first AMI, Kentucky Offender Management System (KOMS) data of 
inmate movements from January 1, 1999 through December 31, 2009 was provided by 
the KY DOC for each of the inmates who had AMIs. KOMS is a database that contains 
demographic data, sentencing information and movement of inmates from prison to 
prison or whenever they leave the prison (i.e., for medical appointments, hospitalizations 
or court appearances). 
Sample  
There were 87 inmates from the six prisons during the period from January 1, 
2005 through December 31, 2009 who had a hospital discharge diagnosis of AMI (see 
Table 4.2). The racial distribution was similar to the Kentucky offender population with 
64.5% Caucasian, 27.5% African American and 8% unknown. In 2009, the KY DOC had 
a racial distribution of 64% Caucasian, 34% African American and 2% other. Of the 87 
inmates who had an AMI, all but one was male. The age range for the sample was 24 to 
84 years of age with a mean of 56.4 years (SD = 11.32).  
The majority of inmates had at least one co-morbidity of diabetes, hypertension 
and/or hyperlipidemia. Seventy-five inmates (86.2%) had hypertension and 71 (81.6%) at 
least two co-morbidities. Only five inmates had no diagnosis of hypertension, 
hyperlipidemia or diabetes. Data were unavailable for four inmates because the EHR was 
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implemented incrementally starting at KSR in June 2005 and the AMI occurred prior to 
that time. 
KSR is the primary medical facility for the KY DOC and 50.6 of the AMIs 
occurred while inmates were living at KSR (n = 44). There were 19 AMIs in the 16 
months prior to the tobacco-free date and 25 in the 43 months after the policy was 
implemented. EKCC is the second largest prison next to KSR. Inmates who are minimum 
security with medical conditions are typically housed at BCC. There were 18 AMIs at 
EKCC, 7 at LSCC and 9 at BCC. Six AMIs happened at BCC prior to the tobacco-free 
date and three occurred after. Two inmates had AMIs while incarcerated in a jail and a 
halfway house. The inmates who had AMIs in the jail and halfway houses are state 
inmates but were housed outside of the 13 KY DOC prisons since approximately 7,000 of 
the 20,000 KY inmates are housed outside of the state prisons.  
The longest stay in one facility was 3,449 days. The majority of inmates moved 
from prison to prison multiple times with only 29 (33%) moving less than once a year. 
The greatest number of moves for one inmate was seven times in one year and the most 
total movements was 24 for one inmate over a 7 year period. The mean number of prison 
moves was 1.1 per year for the total sample. There were four inmates who stayed in one 
prison for the length of their incarceration during the study period. 
Measures 
Time to the first AMI was the primary outcome measure. Since this was a 
survival analysis, subsequent AMIs were not included in the analysis to avoid duplication 
of time intervals. AMI was defined as a hospital discharge diagnosis of ICD-9 codes 
410.0 to 410.99. Demographic data such as age, race/ethnicity, co-morbidities, past and 
current smoking history were derived from the EHR. Age for each time interval was 
calculated as the average age over that time period (‘age during’). Racial data were 
derived from the EHR and were not available for all inmates. Co-morbidities of diabetes, 
hypertension and hyperlipidemia were elicited from the problem list in the EHR.  
A binary variable was created identifying the tobacco policy of the prison during 
a particular time interval. The values of the binary indicator variable for smoking policy 
were ‘1’ (indoor smoke-free policies in which smoking was allowed outdoors) and ‘0’ 
(tobacco-free prisons prohibiting all tobacco products on the grounds of the prison).  
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Facility data were recorded as KSR, EKCC, LSCC, BCC and Location Other. 
Location Other included one AMI at KCIW and eight AMIs that occurred at other 
facilities. CorrectCare recorded the prison to which the inmate was discharged on the 
billing data and eight of the inmates were discharged from hospital to KSR since it is the 
medical facility but had their AMI in other prisons. KOMS inmate movement data were 
used to determine where the inmates were residing at the time of their first AMI.  
Past smoking was recorded as any report of smoking in the chart from the intake 
history, the problem list or the clinical notes. The EHR had documentation that 61 
(70.1%) inmates were past smokers, four (4.6%) had never smoked, and 22 (25.3%) had 
no smoking history information. Current smoking indicates that at the last entry noted in 
the chart, the inmate continued to report that he was smoking. However, after inmates 
moved to a tobacco-free prison in which tobacco was completely prohibited, the 
providers generally did not ask about smoking history. At the last entry documented in 
the EHR there were 49 (56.3%) current smokers and 15 (17.2%) non-smokers, with no 
information on 23 (26.4%) but the quit dates for the non-smokers were not documented 
in relation to the AMI occurrence so current smoking history was not used in the analysis.  
Statistical Analysis 
Cox regression, a type of survival analysis using a proportional hazards model 
(Garson, 2010), was used to analyze the time to first AMI. This regression analysis is 
appropriate for determining the effects of one or more predictor variables on an outcome 
that is censored (i.e., it measures time to an event that may not have yet happened for all 
observations). Those observations for which the event has not yet occurred are treated as 
censored, while those with an event are not censored. In this study, the dependent 
variable was time to an inmate’s first AMI. Each observation or time interval was entered 
as a censored or not censored interval based on whether the AMI occurred during that 
time period. The tobacco policy at each time period was the primary predictor variable. 
The hazard ratio is the main statistical output and indicates the likelihood of an event 
occurring in a given time period which has associated variables (i.e., tobacco policy 
status) compared to another time period that does not have these variables (Garson, 
2010). The hazard ratio is a summary of the probability of events per unit time. If there 
are many unit-times, there is a greater probability of an event occurring.  
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Each time interval had a tobacco-related policy covariate associated with it; this 
variable was a binary variable that indicated whether the facility was smoke-free or 
tobacco-free. Time intervals were the number of days the particular inmate spent at a 
given facility before being moved to another location. KOMS data listed every movement 
after 1/1/1999. In some cases in which an inmate had been committed prior to 1999, the 
first movement from a particular prison was at some future date, indicating that the 
inmate had been housed in that prison since 1/1/1999. The duration of time between 
1/1/1999 and the time of the first movement was calculated. Likewise, the last 
documented movement may have been years prior to the end of the study period. In these 
cases, the date of the last movement until the end of the study period on 12/31/2009 was 
calculated as a time interval since this indicated that the person had stayed at that same 
prison until 12/31/2009. Each time interval was recorded as days which could last for less 
than one day if the person went out and back in a day or potentially up to 4,015 days if 
the person stayed in one facility for the entire 11 years. 
Some of the time intervals extended over the time when the prisons became 
tobacco-free. To account for this situation, the total time period was divided into two time 
periods: one before the tobacco-free policy and one time-period after the tobacco-free 
policy. Table 4.3 provides an example of one inmate’s movements between facilities over 
the study period. The inmate in the example moved to four different prisons between 
1/23/2005 and 12/31/2009, the end of the study period. Between 5/12/2005 and 
2/14/2008, the inmate resided in KCR which became tobacco-free on 5/1/2006. This time 
interval between 5/12/2005 and 2/14/2008 was analyzed as two time periods for this 
inmate, namely before and after the tobacco-free date. For prisons that had not yet 
become tobacco-free by the conclusion of the study period (12/31/2009), the tobacco-free 
date was listed as 1/1/3000 so that any time intervals prior to this date were identified 
with a value of 1 for the binary smoking policy variable (i.e., which indicated smoking is 
allowed outdoors). For example, the inmate in Table 4.3 had an AMI on 2/14/2008. Thus 
for each time interval before this date, the time interval was censored (since the AMI had 
not yet occurred) and the time interval when the inmate was hospitalized for the AMI was 
not censored. The date of the first AMI was the stop date for calculating censored 
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intervals since the survival analysis is designed to determine the time to an event. 
Therefore, the next line of movement after the AMI date was deleted.  
Race, past smoking status, average age during each time period and co-
morbidities of diabetes, hypertension and/or hyperlipidemia were entered as covariates. 
Facility data were entered with five levels including KSR, EKCC, LSCC, BCC and 
Location Other. Two-way interactions were added for policy-smoke by age-during, 
policy smoke by facility, policy smoke by past smoker, and policy smoke by race. The 
model was weighted by the length of time in days that the person was incarcerated 
between 1/1/1999 and 12/31/2009.  
Results 
Proportional hazards model  
The initial proportional hazards model that included the facility tobacco policy 
indicator variable, location, age during each interval, past smoker and race had a good fit 
with a likelihood ratio that was significant (χ2 =.21.95, df=10,  p =.02). The predictor 
variable was the tobacco policy of the facility, i.e., smoke-free (indoors) or tobacco-free. 
The hazard ratio for having an AMI in prisons with an indoor smoke-free policy where 
outdoor smoking was allowed compared to tobacco-free prisons was 3.34. When 
inmates’ co-morbidities were added to the model including diabetes, hypertension and 
hyperlipidemia, the final model had a better fit with a significant likelihood ratio (χ2 = 
36.17, df= 14, p = .001) (see Table 4.4).  in the final model, the hazard ratio for having an 
AMI while housed in a smoke-free prison compared with tobacco-free facilities was 2.87 
(p = .03).  
Having been a past smoker had a hazard ratio of 1.28 compared to being a non-
smoker which was not significant (χ2 = 4.62, df=2, p = .10) but was 2.12 for inmates 
whose smoking history was unknown compared to past smokers (χ2 = 4.05, df=1, p =.04). 
Location was significant for BCC (p = .02) and KSR (p = .004) which had hazard ratios 
of 3.56 and 4.72, respectively, compared to Location Other. Race and age during each 
interval were not significant predictors of time-to-AMI. None of the two-way interaction 
terms were significant including policy smoke*age-during, policy smoke*past smoker, 
policy smoke*facility, or policy smoke*race.  
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The prisons with the highest hazard ratio were two of the tobacco-free prisons: 
KSR which had a hazard ratio of 4.72 and BCC which had hazard ratio of 3.56 compared 
to the group of nine prisons in which there was one AMI each. These results were 
expected since these two prisons are the medical facilities for medium inmates (KSR) and 
minimum inmates (BCC). Inmates with diabetes had an increased hazard for AMI of 1.14 
compared to inmates who did not have diabetes (χ2 = 12.31, df=2, p =.002). The co-
morbidities of hypertension and hyperlipidemia were not significant. After controlling for 
the past smoking history of the inmates, co-morbidities and the prison location, there was 
2.87 times the hazard for AMI in prisons with indoor smoke-free policies compared to 
prisons with tobacco-free policies. 
Discussion 
This is the first study to demonstrate a significant increase in the probability of an 
inmate having an AMI while living in a prison that has an indoor smoke-free policy 
where outdoor smoking is allowed than in a tobacco-free prison, after controlling for 
location, and inmates’ past smoking, age, race and co-morbidities. The hazard ratio 
indicates that for any given period of time the probability of an inmate having an AMI 
goes up 2.87 times in prisons with an indoor smoke-free policy compared to prisons that 
do not allow tobacco products on the grounds. After controlling for the two medically 
intensive prisons (BCC and KSR) which are also prisons that adopted tobacco-free 
policies, there was still an effect of the tobacco policy on the hazard for having an AMI. 
The results of this study suggest that a tobacco-free policy may be an effective 
way to improve the health of inmates by reducing the hazard of having an AMI. This may 
be due to reductions in the proportion of current smoking and in SHS exposure by non-
smokers. Indoor smoke-free policies do not limit current smoking except that they have 
to wait until the yard opens to smoke. The tobacco-free policy is more likely to reduce 
the rate of current smoking and the number of cigarettes smoked since possessing any 
tobacco product is a disciplinary violation. In Kentucky prisons, this is a Category III 
violation (on a scale from I to VII) (KYDOC, 2010).  
Having a known past smoking history was not associated with an increased 
hazard of AMI but an unknown smoking history was associated with more than twice the 
 
62 
 
hazard (hazard ratio of 2.12, p = .04). Of the 61 (70.1%) inmates who were known past 
smokers, nine reported quitting at some point, three had currently unknown smoking 
history and 49 were current smokers at the last documentation in the chart. There were 22 
(25.3%) inmates whose smoking history was unknown. Based on the increased hazard 
ratio for unknown smoking status, it is probable that these inmates were smokers. 
Conversely, the fact that nine past smokers quit smoking, probably resulted in there being 
a non-significant hazard for past smoking status. There were only four (4.6%) inmates 
who had never smoked and who remained non-smokers.  
Current smoking status was not entered in the model because it was not possible 
to determine the quit date in relation to the AMI. Some inmates had documentation years 
after their AMI that they quit when they moved to a tobacco-free prison and a few had 
cardiology reports that they quit after having their first AMI. The prison primary care 
providers tended to stop asking about smoking history once the prisons became tobacco-
free except in one case where the provider noted that the inmate smelled of smoke and 
the inmate confirmed that he had smoked. These data point to the need for providers to 
continually reinforce the need for inmates to quit smoking and to encourage smoking 
inmates to quit regardless of the prison’s tobacco policy. Brief 5-minute interventions by 
providers have been reported by smokers to assist in quitting smoking (Fiore, et al., 
2008). 
It is unknown if the inmates return to smoking when they move from a tobacco-
free prison to a prison with an indoor smoke-free policy that allows outdoor smoking. 
Female inmates in the Indiana Department of Corrections were assessed on stage of 
change to quit smoking before and after the implementation of a comprehensive smoke-
free policy in which no lighted tobacco product was allowed in the prisons or in enclosed 
outdoor areas (Cropsey & Kristeller, 2003). Four days after the prison became tobacco-
free, those who had not considered quitting were more likely to report that they would 
resume smoking on release from prison than those who were contemplating quitting 
smoking (F = 27.2, p <.001).  This persisted one month after the policy was implemented 
(F = 21.8, p <.001). In another Indiana DOC study, 188 male inmates were surveyed 
before and after the comprehensive smoke-free policy was introduced (Cropsey & 
Kristeller, 2005a). One month after smoking was prohibited, 76% of those who were 
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smoking at the time of the policy implementation continued to smoke and 24% had quit. 
Having greater withdrawal symptoms was correlated with continuing to smoke (F = 7.61, 
p <.01). Lankenau (2001) reported that after prisons implemented tobacco-free policies or 
very restrictive smoke-free policies in which no indoor or outdoor smoking was allowed, 
inmates who continued to smoke reported smoking fewer cigarettes per day.   
This study tracked inmates’ movements from prison to prison over the course of 
11 years. The majority of inmates moved from prison to prison multiple times with only 
29 (33%) moving less than once a year with the majority of these residing at KSR due to 
medical needs. On average inmates moved 1.1 times per year but up to seven times in a 
year. In a qualitative study of 40 Australian male and female inmates on the role of 
tobacco in prison, the movement from prison to prison or to a new unit was reported by 
inmates as particularly stressful and more likely to prompt them to smoke (Richmond, et 
al., 2009). Given that inmates move multiple times from prison to prison, there is a 
greater chance that they may relapse if moved from a tobacco-free prison to a smoke-free 
prison. 
Since there are variations in the enforcement of tobacco policies within and 
among prisons, there might be even greater reductions in the hazard for AMI if tobacco-
free policies are enforced consistently. Four of the six prisons in this study were tested for 
PM2.5 in Fall 2009 including two tobacco-free prisons (BCC and KCIW) and two smoke-
free prisons (EKCC and LSCC) (McGuire and Connell, unpublished, 2010). The smoke-
free (indoors) prisons (EKCC and LSCC) had low levels of PM2.5 (mean 8.1 µg/m3) in the 
communal living areas of the medium security dormitories at these prisons until the 
inmates’ cell doors were opened when the level increased to 37.3 µg/m3 indicating that 
inmates were smoking in their cells during the night. The two smoke-free (indoors) 
prisons (EKCC and LSCC) (see Table 4. 1) are predominantly medium security prisons 
with one minimum dormitory outside the fence. The minimum dormitories at EKCC and 
LSCC had less than half the level of PM2.5 than the medium dormitories “behind the 
fence”. An inmate in a medium security prison has little to lose by smoking so may be 
more likely to smoke in his or her cell when there is an indoor smoke-free policy in place 
whereas an inmate in a minimum security dormitory in a predominantly medium security 
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prison might have to return to medium security with many more restrictions if there is a 
disciplinary violation. 
Variations between dormitories may also indicate differing levels of enforcement 
of the policy within the same prison. At BCC, which is a minimum security, tobacco-free 
prison, the highest level of PM2.5 was 30.4 µg/m3 in one dormitory and 11.2 µg/m3 in 
another. The PM2.5 of 30.4 µg/m3 was measured at 6 AM in a dormitory lobby which had 
a central officer’s station. The SHS level could have been from officers smoking on night 
shift or officers who allowed inmates to smoke. Inmates in other minimum security 
prisons have reported that bringing tobacco into a tobacco-free prison is easier with lower 
security levels (Lankenau, 2001). Correctional officers may be lax in writing up 
violations which require a lot of paperwork. The friction resulting from enforcing a no-
smoking policy in cells may be viewed as not worth the cost. The attitude of the 
corrections’ officers toward smoke-free or tobacco-free policies may affect the 
enforcement of these policies. In a survey of 321 Vermont DOC employees, those who 
smoked were much less receptive to comprehensive indoor and outdoor smoke-free 
policies for inmates and/or employees compared to officers who had quit smoking or 
never smoked (p <.001) (Carpenter, Hughes, Solomon, & Powell, 2001).  
Limitations 
The primary limitation of the study was that data from all of the prisons in 
Kentucky were not obtained which would have provided a cross-sectional view of the 
AMIs over the entire KY DOC population for five years. Originally, the aim was to 
compare three prisons with tobacco-free policies to three with smoke-free policies. 
However, the hospital billing data from CorrectCare was recorded with the prison that the 
inmate was discharged to and not admitted to the hospital from, resulting in 13 locations 
in which AMIs occurred. In the future if this study is replicated, all of the AMIs within 
the study time period in all of the prisons need to be included.  
A limitation that is inherent in prison studies and needs to be accounted for in 
future research is that almost all inmates move multiple times over the course of their 
incarceration. The multiple movements from smoke-free (indoors) to tobacco-free prisons 
or from jail, halfway house or parole back to prison create challenges in evaluating the 
 
65 
 
effects of a tobacco-free policy on the risk for an AMI over time. If inmates stayed in one 
prison for an extended period of time before and after a tobacco-free policy was 
implemented or if all of the prisons adopted a tobacco-free policy on the same date, a 
time-series analysis examining the difference in AMI rates pre- and post-policy could be 
conducted. However, in reviewing the inmate movements over the previous 11 years of 
these 87 inmates who had AMIs, inmates resided in all of the DOC’s 13 prisons plus the 
three private prisons. They also spent time out of prison on parole, in jail or in halfway 
houses. Counting the 13 DOC prisons, the three private prisons, jails, halfway houses and 
parole there were 19 possible locations in which this sample of inmates resided over the 
course of the study period. Since moving between prisons has been identified as a 
stressor and a trigger for smoking relapse, future research could add a “movement 
variable” to account for the number of moves for each inmate.  
While the analysis strategy used in this study was able to account for multiple 
movements retrospectively, a case-control study of the potential health benefits of 
tobacco-free prisons could prospectively enroll a representative random sample of 
smoking and non-smoking inmates and follow them through their incarceration in prisons 
with varying tobacco policies for an equal period of years to determine the risks for AMI. 
It would be optimal to assess salivary cotinine or exhaled carbon monoxide as an accurate 
indicator of current tobacco use during multiple time points in the study which has been 
validated in other prison studies to confirm abstinence (Cropsey, et al., 2006; Kauffman, 
Ferketich, Murray, Bellair, & Wewers, 2010). Air quality testing in multiple dormitories 
could be done simultaneously to monitor the enforcement of the policy in each prison. In 
states in which a tobacco-free policy is implemented in all state prisons simultaneously, a 
time-series analysis strategy could be used to determine the rate of AMIs in the years 
before and after the policy was implemented. In this analysis, cases of AMI would be the 
unit of analysis.  
Another limitation of the study was having only one female inmate with an AMI 
which makes the study not generalizable to women. Women in the prison system tend to 
be younger than men and have shorter sentences, which may account for the relative 
absence of AMI events in females, in addition to the fact that women typically tend to 
have cardiac events at an older age. 
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Policy Implications  
The policy implication is clear: tobacco-free policies in prisons decrease the 
hazard for having an AMI. Indoor smoke-free policies place few restrictions on tobacco 
access or on current smokers, even if the policy is enforced, since smoking is still 
allowed outdoors and non-smokers remain exposed to SHS outdoors. In cells with doors 
(as opposed to open dormitories with multiple bunks) it is more difficult to monitor and 
enforce an indoor smoke-free policy where smoking is not visible to the correctional 
officers and non-smokers may be exposed to SHS in their cellblocks. Tobacco-free 
policies are more likely to reduce the rate of current smoking and reduce the number of 
cigarettes smoked by those who take the risk to receive contraband, thereby decreasing 
SHS by smokers and non-smokers alike. Strict enforcement of a tobacco-free policy is 
affected by the security status and the physical layout of the prison (Lankenau, 2001) and 
the attitude of the administration and staff (Carpenter, et al., 2001),. 
Conclusions 
This is the first study to examine the effects of a tobacco-free policy compared to 
an indoor smoke-free policy on cardiovascular health. The results demonstrate that for 
time spent in a smoke-free prison there is a 2.87 increased hazard for having an AMI 
compared to time spent in a tobacco-free prison in which all tobacco products are 
prohibited in the entire prison for staff, inmates, and visitors. Inmates in tobacco-free 
prisons may still be able to smuggle tobacco into prison but they risk having disciplinary 
violations which is a misdemeanor in some states and a felony in others so are more 
likely to at least reduce cigarette consumption even if they do not completely quit 
smoking.   
There are currently 7.3 million people in America who are under some form of 
correctional supervision including jails, state and federal prisons, probation and parole 
(Glaze & Bonzcar, 2009). This is a large sub-population which has high rates of tobacco-
use and consequently high rates of tobacco-related disease. Tobacco-free policies in 
prisons may reduce cardiovascular morbidity and mortality. Given the health and cost 
benefits of tobacco-free prisons, there is a national trend in correctional systems toward 
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adopting tobacco-free policies. The results of this study may accelerate the likelihood that 
prisons will adopt tobacco-free policies rather than less restrictive indoor smoke-free 
policies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Alison R. Connell 
 
68 
 
Table 4.1 Prisons with tobacco-free and smoke-free policies 
Prison Average  
Population
Gender Security Status Smoking Status 
Blackburn 
Correctional 
Complex (BCC) 
594 Male Minimum Tobacco-free 
on Sept 17, 
2007 
Kentucky 
Correctional 
Institution for 
Women (KCIW) 
682 Female Minimum/Medium/ 
Maximum/Death Row 
Tobacco-free 
on July 1, 2007 
Kentucky State 
Reformatory (KSR) 
2005 Male Medium (1987 inmates) 
Minimum (22 inmates)  
Tobacco-free 
on May 1, 2006
Eastern Kentucky 
Correctional 
Complex (EKCC) 
1689 Male Medium (1639 inmates) 
Minimum (50 inmates)  
Smoke-free—
Outdoor smoke 
allowed 
Little Sandy 
Correctional 
Complex (LSCC) 
992 Male Medium (892 inmates) 
Minimum(100 inmates) 
Smoke-free—
Outdoor smoke 
allowed 
Luther Luckett 
Correctional 
Complex (LLCC) 
1073 Male Medium (1029) 
Minimum (44) 
Smoke-free—
Outdoor smoke 
allowed 
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Table 4.2 Demographic characteristics of the sample of inmates with AMI (N = 87) 
Variable n Percent 
Race Black  24 27.5% 
 White   56 64.5% 
 Unknown  7 8.0% 
Gender Male  86 98.9% 
 Female  1 1.1% 
Past smoker Yes 61 70.1% 
 No 4 4.6% 
 Unknown 22 25.3% 
Current smoker 
at last entry in 
chart 
Yes 49 56.3% 
No 15 17.2% 
 Unknown 23 26.5% 
Co-morbidities Diabetes  36 41.4% 
 Hypertension 75 86.2% 
 Hyperlipidemia 64 73.6% 
 One co-morbidity  7 13.8% 
 Two or more  71 81.6% 
Prison at which 
AMI occurred* 
KSR 44 50.6% 
EKCC 18 20.7% 
 LSCC 7 8.0% 
 BCC 9 10.3% 
 Other 9 10.3% 
*KSR-Kentucky State Reformatory, EKCC-Eastern Kentucky Correctional Complex, LSCC-Little Sandy 
Correctional Complex, BCC-Blackburn Correctional Complex, “Other” includes: FCDC-Frankfort Career 
Development Center, GRCC-Green River Correctional Complex, KCIW-Kentucky Correctional Institution 
for Women, KSP-Kentucky State Penitentiary, LAC-Lee Adjustment Center, LLCC-Luther Luckett 
Correctional Complex, MAC-Marion Adjustment Center 
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Table 4.3 KOMS data of one inmate’s movement and censored intervals with the prisons’ 
tobacco policy  
From  To Prison Prison Tobacco 
Policy 
Censored Interval 
1/25/2005  3/8/2005  Jail  Smoke-free Yes 
3/8/2005  4/24/2005  RCC  Smoke-free Yes 
4/24/2005  5/12/2005  EKCC Smoke-free Yes 
5/12/2005  2/14/2008  KSR  Tobacco-free policy was implemented on 5/1/06 so this 
time period was divided into two intervals with tobacco 
policy as the predictor variable as indicated below 
5/12/2005  4/30/2006  KSR  Smoke-free Yes 
5/1/2006  2/14/2008  KSR  Tobacco-free on 
5/1/2006 
Yes 
2/14/2008  2/15/2008  KSR  Tobacco-free No 
AMI Occurred on 2/14/08 
2/15/2008 12/31/2009 KSR Tobacco-free Time interval deleted since 
post-AMI 
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Table 4.4 Hazard ratios for predictors of time to first AMI (N = 87) 
Variable χ2 P value Hazard 
ratio 
Indoor smoke-free policy (outdoor smoking 
allowed) 
4.57 .03 2.87 
Age during the intervals 2.51 .11 1.00 
Race     
 Caucasian 0.78 .68 1.17 
 African American 0.33 .56 0.86 
Location     
 BCC  4.96 .03 3.56 
 KSR  8.23 .004 4.72 
 EKCC  1.95 .16 1.89 
 LSCC  1.41 .24 1.91 
Inmate smoking history    
 Past smoker—yes  4.62 .10 1.28 
 Past smoker—unknown 4.05 .04 2.12 
Co-morbidities     
 Diabetes 12.31 .002 1.14 
 Hypertension  0.99 .32 0.66 
 Hyperlipidemia  .92 .34 1.38 
 
 
 
 
 
 
 
 
 
 
 
72 
 
CHAPTER 5: CONCLUSIONS 
Summary of Findings 
This dissertation was comprised of a literature review and two research studies. 
The literature review discussed the evolution of tobacco-free prison policies, the 
motivators for implementing increasingly restrictive policies and the unintended 
consequences of tobacco-free policies in prisons. Policy outcome studies with the non-
incarcerated population were reviewed as the background for the hypothesized effects of 
tobacco-free prisons on respiratory and cardiovascular outcomes. The first study 
compared the effects of two different types of tobacco policies on respiratory health. Two 
prisons had indoor smoke-free policies in which smoking was allowed outdoors. The 
other two prisons had tobacco-free policies which prohibited all tobacco products on the 
grounds of the prison for staff, inmates and visitors. The second study evaluated the 
effects of the time an inmate spent in prisons with an indoor smoke-free policy compared 
to prisons with a tobacco-free policy on the hazard for having an AMI. 
The literature review of smoke-free and tobacco-free policies revealed that there 
is a continuum of tobacco-related policies among and within states. Most states now have 
indoor smoke-free policies in which smoking is prohibited indoors with outdoor 
designated smoking areas for staff and inmates. Comprehensive smoke-free policies 
cover indoor and outdoor areas but tobacco is not entirely prohibited from the prison 
grounds. The most restrictive policy is a tobacco-free policy in which no tobacco 
products are allowed on the prison grounds for staff, inmates, and visitors.  
The primary unintended consequence of tobacco-free policy implementation in 
prisons is the smuggling of tobacco into prisons which creates a lucrative black market 
for the inmate dealers. Correctional officers sometimes participate in smuggling tobacco 
into prisons, lured by the significant profit which undermines security in the prison. 
Tobacco historically is the main form of informal currency for inmates in prisons which 
make its eradication more challenging.  
There are no reports of studies on health outcomes of smoke-free or tobacco-free 
policies in prisons. In community-based studies of municipalities, states, and countries, 
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there is a large body of evidence indicating that the risk for AMI decreases significantly 
in the year following passage of smoke-free legislation in public places with the risk 
decreasing even more after three years. Respiratory improvements following smoke-free 
laws have also been seen with improvements in respiratory symptoms and in severe 
asthma exacerbations.  
There are studies in prisons that report a reduction in cigarette smoking following 
comprehensive smoke-free and tobacco-free policies, but a surprising proportion continue 
to smoke. Secondhand smoke (SHS) as measured by particulate matter 2.5 (PM2.5) has 
been shown to decrease following the adoption of a tobacco-free policy. However, the 
enforcement of the policy appears to determine the level of secondhand smoke (SHS) 
exposure.  
The first study in this dissertation was a time-series analysis that examined the use 
of inhalers and oral medications by inmates with asthma and/or COPD. Two prisons had 
smoke-free (indoors) policies and two had tobacco-free policies. Immediately following 
implementation of the tobacco-free policy there was a reduction in short-acting inhalers 
such as albuterol. However, the use of these medications gradually increased over the 
next year back to the frequency of use prior to policy implementation. Confounders in 
this study were the rapid turnover of inmates in the tobacco-free prisons and the security 
status of these prisons with many inmates living in minimum security. Inmates in 
minimum security prisons have greater access to the outside world and consequently to 
cigarettes which are often brought into the prison. Future research on the effects of 
tobacco-free policies on respiratory health needs to examine person-level data such as 
smoking history, physiologic measurements of respiratory function and SHS exposure 
and inmate movement data to track admissions and discharges from each prison.  
The second study was a survival analysis to determine the hazard for having an 
AMI given differing time intervals in prisons with smoke-free (indoors) and tobacco-free 
policies. The results of this study demonstrated that there was a 2.87 times increased 
hazard of an inmate having a first AMI in a prison that had an indoor smoke-free policy 
compared to a tobacco-free policy. Person-level data including inmates’ co-morbidities, 
age, race, past smoking history and movement between prisons, jails, halfway houses and 
parole were control variables.  
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Diabetes was the only co-morbidity associated with an increased hazard ratio of 
1.14 compared to inmates without the diagnosis. Hypertension, hyperlipidemia, age and 
race were not significant. Having documentation of being a past-smoker was not 
associated but having no documentation in the chart of smoking history had a 2.12 hazard 
ratio of AMI which may be an indication of current smoking. Two of the tobacco-free 
prisons had 3 to 4 times the hazard for AMI compared to the other prisons but these were 
the minimum and medium medical facilities for the state and house the sickest inmates. 
After controlling for the past smoking history of the inmates, their medical conditions and 
the prison location, there was still 2.87 times the hazard for AMI in prisons with indoor 
smoke-free policies compared to tobacco-free prisons. 
Limitations of this study were that inmates’ smoking history was not readily 
available in the electronic health record (EHR) prevented determining if inmates were 
current smokers at the time of their first AMI. The second main limitation was that the 
billing data were recorded by the prison the inmate was discharged to and not the prison 
in which the AMI occurred which resulted in 13 prisons in which the AMI occurred 
rather than the original six. The tobacco policies of all the study prisons were included in 
the model. If this study were to be replicated, all of the AMIs from the KY DOC prisons 
during the study period would be included to give a cross-sectional view of the entire 
state.  
These two dissertation studies are the first to report on health outcomes secondary 
to tobacco-free prison policies. The AMI study was also the first to incorporate the 
multiple movements of an inmate population among prisons within one state. The 
movement of inmates between prisons is a major challenge in prison policy outcome 
research. In the respiratory study, the results may have been affected by inmates’ 
movement among prisons but this was not tested since the data were derived from the 
pharmaceutical company for the state. It was not feasible to track over 1,100 inmates’ 
movement over three years. In the AMI study with a smaller samples size (N = 87), the 
frequency of inmate movements was calculated by specific time intervals and included in 
the model with a predictor variable indicating the tobacco policy of the prison at a point 
in time. Most inmates moved from one prison to another an average of once per year but 
some moved multiple times in one year.  
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Research Implications 
Findings from these studies support the need for further research that examines 
the effects of the continuum of smoke-free to tobacco-free prison policies on health 
outcomes on both inmates and correctional staff. In states such as Kentucky that have 
different strengths and scopes of tobacco policies it is more difficult to determine the 
effect of the policy on a particular health outcome. If these studies were to be replicated, 
all state prisons over the same time period would need to be included and all inmates’ 
movements tracked over an extended time period before and after policy implementation. 
Future research would also include a movement variable to account for the number of 
movements by each inmate during the study period. The best time to evaluate the effect 
of a tobacco-free policy is when an entire state increases the strength and scope of the 
existing tobacco policy such as in Nevada, North Carolina, Virginia and Georgia which 
are all becoming tobacco-free in 2010. States such as Kentucky where tobacco policies 
vary prison by prison make it harder to evaluate the effect of the policy since inmates 
move frequently from one prison to another.  
There are three main methods for evaluating the effect of tobacco-related policies 
on the health of inmates. One is a population-based analysis of a particular health 
outcome such as the cases of AMI in the year before and after the implementation of a 
tobacco-free policy in all prisons across the state. This would be more challenging if the 
policy was not implemented simultaneously on the same date in all prisons. This method 
would be similar to studies in the non-incarcerated population in Helena, Montana and 
Piedmont, Italy in which the age-adjusted incidence rate in the pre-policy period was 
compared to that of the post-policy period (Barone-Adesi, et al., 2006; Sargent, et al., 
2004).  
The second method would be a prospective, longitudinal study with a pre-post 
design but with a smaller convenience sample that includes person-level data such as 
physiologic measures such as cotinine levels and pulmonary function tests, co-
morbidities, smoking history, length of incarceration and sentencing data, and movement 
among, and in and out of prisons. These would be measured preferably for at least a year 
prior to the tobacco-free date and then at intervals in the post-policy implementation 
period. The health outcome could be the number of cases (e.g., AMI) or a physiologic 
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marker (e.g., FEV1) which could be entered into a regression to determine the likelihood 
of the particular health outcome while controlling for facility and person-level variables.  
A third way of analyzing the effect of tobacco policies on health outcomes in 
prisons would be a cost-analysis on AMIs for a period of time. Again, simultaneous 
adoption of a tobacco-free policy in all state prisons would be the best scenario for this 
analysis. Cost-analysis requires a complex mixed-model design that includes random and 
fixed effects such as facility, rate of admissions and discharges to the state, inflationary 
costs, and fixed costs such as for staff and overhead. 
Practice Implications 
The main factor that facilitated the two health outcome studies of the tobacco 
policies in Kentucky was the partnership between the KY DOC and the University of 
Kentucky: Kentucky Corrections Health Services Network (KCHSN). KCHSN 
streamlined and centralized the health care of the inmates in Kentucky by hiring a health 
care management company and a single pharmaceutical company. The health care 
management company provided the data for the AMI events, and the pharmaceutical 
company provided the data on medications by disease type. Both of these companies 
have a sophisticated, electronic database which can track data by time, inmate, and ICD-9 
code. The electronic health record facilitated chart review since every inmate in the state 
has a health chart. Prior to this, each prison contracted with individual and primarily local 
vendors and paper charts were used, both of which precluded systematic policy analysis 
research. There are few State Departments of Corrections that have a university 
partnership but this is recommended to increase the quantity and quality of health-related 
research on the incarcerated population since at any given time there are over 7 million 
people under correctional supervision including 2.3 million people in prison and 
approximately 5 million on parole and probation (Glaze & Bonzcar, 2009).  
The most important practice implication of the studies reported here is that 
primary care providers need to regularly assess and document details of inmates’ 
smoking history. This allows for tracking of the quit date in relation to health outcomes. 
Providers need to encourage inmates to consider permanent smoking cessation regardless 
of the tobacco policy of the particular prison since the literature indicates that inmates 
 
77 
 
continue to find ways to smoke even in tobacco-free prisons and they tend to resume 
smoking after discharge from a tobacco-free prison (Thibodeau, Jorenby, Seal, Kim, & 
Sosman, 2010). Ninety-five percent of inmates will eventually be discharged and many 
return to smoking upon return to their home communities (Sabol, et al., 2009; Thibodeau, 
et al., 2010). Incarceration may be a time when inmates can achieve prolonged abstinence 
from tobacco. 
Tobacco dependence treatment needs to be offered to inmates regardless of the 
tobacco policy of the prison since approximately 70% of inmates are current smokers on 
entry to prison. Tobacco cessation classes have been offered to inmates with varying 
degrees of success. A tobacco cessation program, using a mood management training 
behavioral intervention once a week for 10 weeks combined with nicotine replacement, 
was provided to a purposive sample of 250 female current smoking inmates (Cropsey et 
al., 2008). Of the 116 who completed the intervention, quit rates were 18% at the end of 
the program, 17% at three months and 14% at six months which is consistent with quit 
rates in community cessation programs. In Australia, in a prison with 330 male inmates, 
30 signed up for a smoking cessation intervention which included two brief cognitive 
behavioral therapy sessions, nicotine replacement gum, bupropion and self-help 
resources. At six months, eight (26%) were abstinent which was confirmed by exhaled 
carbon monoxide measurements.  
Despite promising results of tobacco treatment in prisons, a survey of 100 
correctional administrators reported that tobacco cessation programming is not a high 
priority in correctional facilities (NCCHC, 2004). Eighty percent reported that they have 
no tobacco cessation programs in prisons regardless of the status of the tobacco policy of 
the environment. It is recommended that prison health care providers such as physicians, 
nurse practitioners and nurses offer tobacco dependence treatment as they would for any 
other chronic, relapsing health condition (Fiore, et al., 2008). 
Policy Implications 
The results of the AMI study reporting a hazard ratio of 2.87 for having an AMI 
in a smoke-free prison compared to completely tobacco-free prisons has significant 
policy implications for State Departments of Corrections that are considering becoming 
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tobacco-free (vs. smoke-free) and for prisons within Kentucky that have not yet become 
tobacco-free. Since current smoking prevalence data were not available, it is not clear 
whether the reduction in hazard at tobacco-free prisons was related to reductions in 
personal smoking, SHS exposure or a combination of the two. Regardless, the policy was 
associated with reductions in the hazard of AMI despite expected differences in levels of 
enforcement in the prisons and after controlling for unique characteristics of the prisons. 
The result of this study will be shared with the Medical Director for the KY DOC and the 
Commissioner of the KY DOC as well as with individual wardens of Kentucky prisons 
who may consider strengthening the existing indoor smoke-free policies to tobacco-free 
prison policies.  
Conclusion 
This dissertation is the first study to examine health outcomes following adoption 
of a tobacco-free policy in prisons. The first study which examined medications for 
asthma and/or COPD as a proxy marker of respiratory health did not yield conclusive 
results on the effect of the policy. There was an immediate reduction in short-acting 
inhaler use for respiratory symptoms but this effect was not sustained over the following 
18 months. However, the study with AMIs as the dependent censoring variable in a 
survival analysis which included  person-level data, determined that there was a hazard 
ratio for having an AMI of 2.87 in prisons with an indoor smoke-free policy compared to 
prisons with a tobacco-free policy, in which no tobacco is allowed on the grounds of the 
prison. These results are consistent with policy outcome studies in the non-incarcerated 
population that show reductions in the risk for AMI after passage of smoke-free 
legislation. There are no equivalent, free-world studies of tobacco-free policies since non-
incarcerated current smokers are at liberty to smoke when away from the location 
covered by the law without fear of disciplinary action while inmates risk disciplinary 
violations by possessing or using tobacco in tobacco-free prisons.  
Tobacco in prisons has an added dimension in that inmates consider it as informal 
currency. This increases its demand and value as smuggled contraband after prisons 
become tobacco-free. In prisons with comprehensive tobacco-free policies, the rate of 
current smoking decreases as the policy becomes more restrictive and as the security 
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status of the prison increases. Tobacco typically overtakes heroin as the number one 
contraband item following a tobacco-free policy (Garland, 2006) but as one Kentucky 
warden who implemented a tobacco-free policy in her prison said, “I would rather chase 
tobacco than drugs any day. It’s fiscally and ethically the right thing to do” (personal 
correspondence, Warden Crews, June 22, 2010).  
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